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2Abstract
Porous organic networks, prepared by supramolecular assembly of carefully selected
building units, have potential biological applications as drug carrier, molecular
sensors and more. In these materials two types of molecules, called nodes and linkers,
are connected by hydrogen bonds to form open 3-dimensional networks.
In the current project the selection of linker and node compounds was inspired by
hydrogen bonding between the DNA nucleobases adenine and thymine. Linkers with
an aliphatic chain of variable length (I) and node molecules derived from
tetraphenylmethane (II) were successfully synthesized. Synthesis of other node
compounds derived from adamantane (III) and tetraethylmethane (IV) proved to be
challenging.
X-ray diffraction data were collected for three different types of crystals. 9,9’-
dimethylene-bis(adenine) was obtained as a remarkably stable tetrahexafluoro-2-
propanol solvate. Two modifications of tetrakis(4-thyminylmethylphenyl)methane,
3grown with methanol or 2-propanol as precipitating solvent in vapor diffusion
experiments, also have exceptionally high solvent content for a molecular crystal,
with either 2-dimensional or 3-dimensional solvent regions calculated to account for
35 or 47 % of the unit cell volume. Both types of crystals decayed instantly when
removed from the mother liquor, and had to be flash frozen in liquid nitrogen before
being transferred to the X-ray diffractometer. In the crystals investigated hydrogen
bonds are formed between adenine moieties (linker molecule) or thymine moieties
(node molecules). The intended formation of interactions between adenine and
thymine in a co-crystallized linker-node complex did not take place, probably due to a
mismatch in the solubilities of the linker and node substances in various solvents.
4Abbreviations and acronyms
1. General
A
Aq.
Adenine
Aqueous
COSY
COF
Correlation spectroscopy
Covalent organic framework
d dublet (NMR)
DCM Dichloromethane
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Electrospray mass
Triethylamine
EtOAc Ethyl acetate
h
HFP
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1,1,1,3,3,3-Hexafluoro-2-propanol
HMBC Heteronuclear multiple bond correlation experiment
HRMS High resolution mass spectrometry
HSQC Heteronuclear single-quantum coherence
Hz
IPA
Hertz
Iso-propanol
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m multiplet (NMR)
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Me
MEK
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Methyl ethyl ketone
MHz
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5Hertz Iso-propanol
J
Coupling constant (NMR)
m
multiplet (NMR)
M+
Molecular ion peak (MS)
Me
MEK
Methyl
Methyl ethyl ketone
MHz
MOF
Megahertz
Metal-organic framework
MS
Mass spectrometry
M.p.
Melting point
m/z
Mass to charge ratio
Ph
PXRD
r. t.
Phenyl
Powder X-ray diffraction
Room temperature
s
singlet (NMR)
sat.
Saturated
t
T
Temp.
triplet (NMR)
6Thymine Temperature
TFA
Triflouroacetic acid
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Thin layer
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XRD
X-ray diffractions
2. For this project
AdC2Ad
9,9’-Dimethylene-
bis(adenine)
AdC3Ad
9,9’-Trimethylene-
bis(adenine)
ThC2Th
1,1’- Bimethylene-
bis(thymine)
ThC3Th
1,1’- Trimethylene-
bis(thymine)
Th4
Tetrakis(4-
thyminylmethylphenyl)m
ethane
Ad4
Tetrakis(4-
adeninylmethylphenyl)m
ethane
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Part I
Introduction
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1. Supramolecular materials
Supramolecular chemistry is a branch of chemistry describing chemical systems
generated from a number of self-assembled molecular components. 1 Supermolecule
is the complex of molecules held together by noncovalent bonds under control of
thermodynamics, molecular environment and solvent influence using one or more
types of functional building units. 2-4 Supramolecular assemblies utilize the weak and
reversible noncovalent interactions, including hydrogen bonding, metal coordination,
dipole-dipole interactions, van der Waals forces, π-π interplay and electrostatic
interaction, while traditional chemistry mainly focuses on formation of covalent
bonds.1, 2
The primary building units used to construct the molecular framework are the nodes
serving as joint points and the linkers connecting them. The linkers may be linear,
while the nodes have planar or three-dimensional configurations. The composite unit
of linker and node molecules is a secondary building unit (Figure 1).
Figure 1: A general construction of framework from node and linker
materials.
Commonly used linkers are functionalized polyether chains, biphenyls or triphenyls,
and simple alkyl chains.5 Well studied nodes are metal ions or clusters of metal ions
and 3D organic materials as shown in Figure 2.
12
2. Crystal engineering
The aim of crystal engineering is the design and synthesis of new solids with desired
physical and chemical properties, based on the understanding of intermolecular
interactions in the context of crystal packing.6 Unlike the traditional organic chemistry,
which concerns the formation and cleavage of covalent bonds, crystal engineering
focuses on hydrogen bonding and coordination complexation of networks. An
important step forward in the understanding of the organization of molecular crystals
is to introduce a concept called the supramolecular synthon defined as a structural unit
within a supermolecule that can be formed and/or assembled by known or conceivable
synthetic operations involving intermolecular interactions (Figure 3, 4).7-9
Figure 3: An example of supramolecular synthon. The synthon duplicates
to form a chain of starting materials..9
Figure 4: Examples of some common supramolecular synthons found in
organic and biological systems. A synthon can be formed through single
or multiple hydrogen bonds.
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Synthons recur in several crystal structures and can be regarded to play the same role
as functional groups do in traditional organic synthesis (Figure 5). Recognition of
supramolecular synthons is based on the determination of specific intermolecular
interactions like hydrogen or halogen bonds, stacking interactions and so on. Hence
they provide a degree of predictability when constructing crystals.
Figure 5: Self-assembly of supramolecular synthons via hydrogen bonds.
10 Based on a synthon, different crystal structures can be designed.8
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During the past two decades, supramolecular chemistry and crystal engineering have
made significant achievements in areas of catalysis,11 separation,12 pharmaceutics, 13
and energy storage. 14 Nowadays, the study of supramolecular chemistry and crystal
engineering contributes to both structural and functional materials and helps to
understand many biological processes. In turn, biological systems often serve to
inspire the effort.10 The success of crystal engineering relays on the synthesis,
crystallization, crystal structure analysis, and computational methods.15
3. Porous organic networks
A porous organic framework consists of numerous building units assembling to form
a periodic and uniform pore structure leading to unique physical and chemical
properties.16 For such a porous framework, the pore size is the most important
parameter. Hence, organic porous materials have attracted considerable attention due
to their adjustable pore sizes and stabilities, which ultimately depends on the
structures and nature of the linker and node compounds. For instance, the length of
phenyl ring systems or carbon chains in the linker molecules determine the pore sizes
when forming distinct frameworks (Figure 6). 17
15
Figure 6: A series of metal-organic frameworks (MOFs). Blue polyhedral:
metal cluster; gray spheres: C; red spheres: O; white spheres: H; large
yellow spheres: pore space. Longer linker material gives larger free
volume. 18, 19
3.1. Classification of porous network
Based on the composition and interaction of building units, porous organic
frameworks can be mainly classified into three classes: covalent organic frameworks
(COFs), 20-22 metal–organic frameworks (MOFs), 23-25and hydrogen-bonded organic
frameworks. 26, 27
COFs are constructed by formation of covalent bonds between starting materials
containing only light elements (H, B, C, N, and O), such as COF-1 (Figure 7).28-31
16
Figure 7: Schematic representation of assembly of COF-1. Condensation
reaction of benzene-1,4-diboronic acid gives 2D supermolecular layers,
which stack to form 3D porous framework. 32 Red: oxygen; yellow: boron;
gray: carbon.
MOFs are crystalline networks consisting of metal ions or clusters (as nodes)
coordinated to rigid organic molecules (as linkers) to form 3D frameworks by
stacking layers (Figure 8).20, 33-36
Figure 8: Construction of MOF-5. Zn: green spheres or blue tetrahedrons,
O: red spheres, C: black or gray spheres, H: blue spheres. The large
yellow spheres represent the largest molecule that could fit in the cavities.
21, 37
Hydrogen-bonded organic frameworks are directly self-assembled from purely
organic building blocks only via hydrogen-bonding interactions between node and
linker molecules or only one type of molecules (Figure 9). 38-41
17
Figure 9: Crystal structure of a hydrogen-bonded framework SOF-1. L1
is the building unit molecule. (a) View of the molecular structure and
hydrogen bonding for the symmetric unit. (b) View of 3D porous organic
framework. (c) Side view of the channel. The channels are shown in
yellow. C: black spheres; H: light blue; N: dark blue; hydrogen bonds: red
dashed lines.26
(a)
(b) (c)
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3.2. Functions and principles of porous organic network
Organic porous networks have shown potential applications in gas storage, 14, 42,43
separation,12, 44 catalysis,11, 45drug delivery and sensing13, 46 due to their easy-
accessible high surface area, tunable pore functionality and structural flexibility. 47, 48
The functional principle of these materials rely on the tunable pore or channel volume
and the interaction between host and guest molecules to allow target guest molecules
to fit into the pore under required dynamic control.30, 49, 50
Additionally, a high surface area allows the exposure of numerous active sites binding
to more guest molecules adsorbed in the framework. 51 Another interesting and unique
principle has been described as ‘breathing’ or ‘gate opening’.44 This phenomenon
occurs in the presence of structural flexibility of the frameworks. The thermal control
or the change of the molecular environment allows the pore to deform so that the
guest molecules can be released or adsorbed (Figure 10).52, 53
Figure 10: The functional principle of zeolitic imidazolate framework
ZIF-8. (a)Scheme shows the form transition upon guest molecule
adsorption under the thermal control. (b) Relation between transition and
temperature. Bule sphere: guest molecules.53
(a)
(b)
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3.3. Study of porous organic network
Because of the applications mentioned above, many novel organic porous frameworks
have been successfully designed and synthesized in the last decade. 54-57Classic porous
materials, like MOFs and COFs have been developed to a large extent with various
void volume and internal surface area.
When comparing the three main types of porous organic frameworks, COFs have
rigid structures with large surface areas and high thermal stability due to the strong
covalent interactions, but the formations of these bonds have to undergo specific
reactions such as condensation reaction.31, 52 It means that the selection of reaction
conditions plays an essential role for establishing the framework. Most of the well-
studied starting materials of COFs have planar configurations (Figure 11), so the
open networks are usually obtained by stacking of numerous 2D layers.
Figure 11: Some commonly used building blocks for COFs. 9 is a 3D
structure, while 1-8 have planar configurations.37
By contrast, MOFs and hydrogen-bonded organic frameworks are the candidates
assembling through noncovalent interactions. These types of frameworks usually
provide high-symmetry 3D structures described as ‘cages’.58 MOFs require mild
synthetic conditions even at room temperature.59 Abundant organic linker materials
and metal ions or clusters are readily designed and studied, so there are many options
of building units and combinations for predictable frameworks.59
20
Hydrogen-bonding organic frameworks are usually not robust enough to exhibit
permanent porosity in the absence of guest molecules. 32 It is known that in many
frameworks the pores are filled with some solvent molecules as guests, and they will
collapse upon the removal of those molecules, because the hydrogen-bonding
interactions are so weak that they are easy to split, once the pores lose the support of
solvent molecules. 41, 60-64
4. DNA base pairs
Naturally occurring DNA is an essential self-assembling structure.65 The DNA double
helix structure is constructed by two coiled hydrogen-bonded strands, which are
composed of sugar-phosphate backbones and nucleobases To keep the distance
between two antiparallel strands, each type of bicyclic nucleobase guanine (G) or
adenine (A) bonds with just one type of single ring nucleobase cytosine (C) or
thymine (T) (Figure 12). This is called complementary base pairing.66 Hence, adenine
bonds only to thymine with two hydrogen bonds, and cytosine bonds only to guanine
with three hydrogen bonds. 67
SugarPhosphate
Figure 12: A fragment of DNA double helix. Noncovalent hydrogen
bonds between the nucleobase pairs are shown as dashed lines. Two
hydrogen bonds exist between adenine and thymine, while three between
guanine and cytosine.67
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In the organism, the sequence of these base pairs in DNA expresses and controls the
genetic information. It is worth noting that the hydrogen bonds of each base pair are
decisive for the construction and stability of DNA double helix.68
According to the property of highly controlled molecular recognition between two
matching nucleobases, DNA based materials have been probed in many cases. A new
type of porous solids making use of bioinspired molecular fragments of nucleobases
or nucleobase derivatives as functional groups has been developed. 69 DNA base
molecules could act as part of building blocks for assembling nano materials and
molecular devices.70 Nucleobase Zn(II) complexes with nuclease activity and
cytotoxicity has been synthesized and investigated based on DNA binding property.
72DNA base pairs can be regarded as a type of supramolecular synthons due to their
complementary multiple hydrogen bonding donor and acceptor sites. 73
5. The aim of the project
In this program, considering all functions, principles, merits and shortcomings of
MOF, COF and hydrogen-bonded organic framework, we aim to build a series of
porous crystalline frameworks using DNA bases as a part of the building blocks. Our
target molecules were aimed to self-assemble into 3D networks via intermolecular
hydrogen bonds between DNA base pairs instead of using metal clusters or covalent
bonds. To obtain the 3D structure, the node molecule should extend towards three
dimensions. This means that the organic node cannot be planar, but must have a
polyhedral molecular structure. Since the carbon atom forms maximum four single
bonds, the obvious 3D node structure is tetrahedral.
Due to the high reactivities of C-6 carbonyl group and C-2 amino group in guanine,
protecting ans deprotecting reactions at these positions are always required to undergo
N9-alkylation.74, 75 Therefore, more complicated synthetic routes may be needed.
Concerning this complexity, we selected the DNA base pair A-T rather than C-G as
the option for synthesizing the building units of the self-assembling frameworks.
When not incorporated into double helix, adenine can interact with itself, and the
same for thymine.70 Therefore, there are three predicted binding motifs (Figure 13).
22
Figure 13: Three possible bonding types of adenine (A) and thymine (T):
A-T, T-T, A-A.
Two target classes of networks are designed (Figure 14). In class A, both node and
linker are used. Each linker connects to two nodes, while each node attaches four
linkers. In class B, only one or two node compounds are involved, and the ratio
between two different nodes should be 1:1.
Linker
Node
23
Node 1 Node2
Figure 14: Two target classes of networks. Circled N: core of node
molecule; A: adenine; T: thymine; Dashed line: hydrogen bonds; curved
line: two or three carbon chain of linker molecule.
Serving this goal, we planned to synthesize two distinct series of materials, which are
linear linkers and tetrahedral nodes. The target compounds to be synthesized are
specified in Table 1.
24
Table 1: Target compounds for synthesis
Adenine derivatives Thymine derivatives
Syntheses of these compounds in Table 1 could be possibly realized through N-
alkylation reactions of heteroaromatic adenine or thymine.75-80 The syntheses of linker
compounds have been reported, 81-83 while the node compounds have not been
prepared yet.
25 
 
6. Challenge 
Although some DNA base, such as adenine, have already been investigated in metal-
organic framework or complex and the new solid materials,
84 , 85
 the potential of 
nucleobases as tools in supramolecular chemistry has not yet been fully exhausted.  
Two main reasons are the low solubility of the nucleobase derivatives in common 
organic solvents and the synthetic challenges due to their chemical properties.
 
Specifically, due to the low solubility of the adenine and thymine derivatives in 
common low or moderate polar organic solvents, the achievement of crystals that can 
be used for structural analysis is hampered.
69
 Both adenine and thymine have several 
sites susceptible to alkylation. It was therefore necessary to employ procedures that 
gave alkylation at the desired site, and in some cases protecting groups have to be 
introduced.
77
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Part II
Strategies and methods
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7. Synthetic methods
7.1. N-alkylation of adenine and thymine
7.1.1. N-alkylation of adenine
Figure 15: The structure of adenine and the accepted numbering system.
Adenine is also known as 9H-purin-6-amine (Figure 15). The NH proton in adenine
is acidic and can be easily abstracted by a base, and this property mainly leads to the
N-alkylation of adenine.86 Adenine, as a derivative of purine, has four NH-tautomers
(Scheme 1). Under the specific conditions, N-3, N7- and N9- substituted products
may be obtained from reactions. N9- and N7-alkylations are always achieved under
basic conditions, and N9-alkylation is observed more often as the major product. 87, 88
Scheme 1: Adenine tautomers, and the resonance forms of its anion in
basic condition.
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Base-induced coupling is the most known general method of the alkylation reactions.
It consist of generating a anion in the presence of a base such as alkali metal
carbonates such as K2CO3, or hydride (NaH) in a polar solvent.77, 79, 89 The use of
K2CO3 and NaH as bases, stimulate the deprotonation at N9 position of adenine. Then
alkylation reagent as an electrophile attacks the N9 position. In some cases, the N7
isomer or N3 isomer may be obtained as a side product of the N9-alkylation reaction,
especially when protected or modified adenine is used. 90- 93 The aim of this project is
to obtain the N9- substituted product (Scheme 2).
Scheme 2: N9-Alkylation mechanism of adenine.
7.1.2. N-alkylation of thymine
Figure 16: Molecular structures of uracil and thymine.
Thymine known as 5-methyluracil, is found in DNA, while in RNA, uracil replaces
thymine as the nucleobase (Figure 16). Based on their molecular structures, they have
similar chemical properties.
Monoalkylation of uracil or thymine generally has low selectivity. Therefore the
N1,N3-dialkylated or N1,O2-alkylated derivatives are usually obtained as side
products. Alkylation of the unprotected uracil with ethyl iodide was reported to give
both N1-ethyl and N1,N3-diethyl derivatives. 94, 95 N1-alkylated uracil with allyl
29
bromide and potassium carbonate in DMF solution was isolated, but in a low yield.96
Under Mitsunobu conditions N1- and O2-alkylation have been observed. In this
project, N1-alkylated compounds are desired. Hence the protecting groups should be
introduced at N3- or O2- position. Several protection strategies have been reported. 44,
96, 97
7.2. Short methylene chain
Due to the wanted shape of our linker molecules, and to avoid the formation of
intramolecular hydrogen bonds, we choose di- and tri-methylene chain halide reagents
as the starting materials for syntheses of linker compounds (Figure 17).77
Dimethylene chain allow the target molecule having a straight structure and a
symmetric center, while trimethylene chain bends at central carbon, so it has a
symmetric axis. Both of their compact molecular structures can restrict the flexibility
of the aimed framework. These simple alkyl halide reagents are commercially
available. In general, primary alkyl halides are great substrates in the SN2 reaction.
The aimed linker compounds have been synthesized following literature routes.77, 78
Figure 17: Molecular structures of starting materials, 1,2-dibromoethane
(2) and 1,3-dibromopropane (3).
7.3. Pentaerythrityl adenine or thymine materials
The central carbon of pentaerythrityl is tetrahedral (Figure 18). The designed node
compounds based on this structure have potential to lead the formation of 3D
frameworks when connecting with linker molecules. The fixed bond angle (109.5o) of
central carbon atom and the steric hindrance of large functional groups will restrict
the bending at the CH2 groups. In this case, there should be little flexibility in the
pentaerythrityl derivatives. The syntheses of pentaerythrityl tetrabromide and
pentaerythrityl tetraiodide have been reported.76, 98 Using these tetrahalides as
alkylation reagents for adenine or thymine, the reaction prefer to undergo a SN1
mechanism (Figure 19).
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Figure 18: Structure of pentaerythrityl. Central tetrahedral carbon atom is
shown. Curved line: connection of functional group.
Figure 19: Designed node molecules: pentaerythrityl tetra adenine and
pentaerythrityl tetra thymine.
7.4. 1,3,5,7-Bromoadamantane
Due to its rigid cage structure, adamantane is a candidate tetrahedral building block,
which has potential to form 3D structure framework.99-101 Many bridgehead
substituted adamantane derivatives, including N-adamantylated products, have been
synthesized by nucleophilic substitution in the presence of a Lewis acid.102,103 Tetra
bridgehead functionalized derivatives are less common, because they are often more
difficult to synthesize (Scheme 3).104 Substitution of adamantane at the bridgehead
positions requires the activation of a tertiary C–H bond, so it means the requirement
of harsher reaction conditions. Due to the strain of the cage structure of adamantane,
the bridgehead carbon cannot form a planar configuration, so the backside attack is
impossible at bridgehead positions. Hence the haloadamantanes cannot participate in
SN2 reactions. SN1 reactions on bridgehead halides may also be difficult since the
carbocation intermediate is not planar.105
31
Scheme 3: From adamantane to tetra-bromoadamantane, then to tetra
DNA-base adamantane.
Compared with pentaerythrityl adenine or thymine derivatives, the distance between
each bridgehead carbon in adamantane structure theoretically reduces the steric
hindrance of adenine or thymine substituents when polysubstitution occurs. Therefore,
the adamantane derivatives were designed as a series of alternative node compounds.
7.5. Tetrakis(4-(bromomethyl)phenyl)methane
Figure 20:Molecular structure of tetrakis(4 (bromomethyl)phenyl)methane.
According to this molecular structure, there is a relatively bulky connecting group on
α-carbon, so the nucleophilic substitution prefers to follow the SN1 mechanism
(Figure 20). Although the CH2 groups in this structure will provide the node
molecules with higher flexibility while forming network, this kind of compounds
α
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should also be easier to synthesize. In comparison, the carbocation (b) can be
stabilized by resonance of benzene ring system, while the carbocation (a) would be
more difficult to form due to the breaking of the aromatic electron system (Scheme 4).
Hence, as a candidate, tetrakis(4-(bromomethyl)phenyl)methane was more reliable.
Compared to pentaerythrityl bromide, 1,3,5,7-bromoadamantane and tetra p-
bromophenyl methane, tetra (p-bromomethylphenyl) methane is more reactive for
SN1 substitution reaction, because of the formation of more stable
carbocation
Scheme 4: (a) The carbocation of tetra p-bromophenyl methane is
difficult to form. (b) The promising carbocation formed from tetrakis(4-
(bromomethyl)phenyl)methane could be stabilized by four resonance
forms.
8. X-ray crystallography
33
X-ray diffraction (XRD) is the most powerful method for providing structural
information for crystalline networks. The results from processed and refined
diffraction patterns provide reliable and required parameters for 3-dimensional
molecular structures and determination of the absolute configuration of the
molecules.88, 92 In the past decades, X-ray diffraction methods have improved rapidly,
especially for the diffraction data collection procedures. The usage of area detectors
as an electronic version of photographic film reduced the data collection time by
recording many reflections simultaneously. 106, 107 Impressive advances in computer
hardware and software development shorten the time to solve and refine a structure
from days or weeks to hours.107 The application of constant low temperature obtained
from a cold gas stream by evaporation of liquid nitrogen makes it possible to slow the
radiation damage of X-ray beams for crystals, and reduce the thermal vibrations,
which give a more well-defined electron density and more accurate structure
determination.94
A powder X-ray diffraction (PXRD) pattern is the ‘fingerprint’ for a compound, and
both the positions and the relative intensity of the peaks in a diffraction pattern are
indicative of a particular phase and material. A database is available for such
‘fingerprints’ of most chemical compounds, for which a crystal structure has been
solved. Once two compounds interact via any interaction, including H-bond, a new
pattern will form for the complex with characteristic signals belonging to neither of
them.
Single crystal X-ray diffraction effectively provides reliable information about the
parameters of the unit cell and lattice. This method can be employed to determine the
configurations and disorder of molecules, since the electron density map indicates the
real atomistic locations (Figure 21). 108-110
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Figure 21: Four main steps of single crystal X-ray diffraction analysis.109
9. Crystal growth
All strategies for crystallization are aimed at bringing a concentrated solution of a
homogeneous population of molecules very slowly towards a state of minimum
solubility.106 The size and shape of the obtained crystals vary tremendously on the
chemical natures of the compounds,111 as does the solubility in different solvents. The
selection of solvent and precipitating reagent is consequently important for the crystal
quality.
9.1. Slow evaporation
Slow evaporation is the quickest and easiest crystallization process depending on the
choice of solvents and sometimes it is combined with temperature control. The
evaporation of solvent leads to a rise of the concentration of the solute until crystals
form (Figure 22).109
Figure 22: Crystal growth: slow evaporation.
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This method is aimed at bringing a concentrated solution of homogeneous compounds
very slowly toward a state of super-saturation, from which the crystals grow. It is
undesirable to let a solvent evaporate to dryness as this will allow crystals to become
encrusted, grow into an aggregate or be contaminated by impurities.108, 109 The
crystals may be degraded by loss of co-crystallized solvent, and sticked on the walls
of container furthermore cause the problem when harvesting the crystals.
9.2. Solvent layering
Another commonly used technique is solvent layering (Figure 23). One solvent
should be carefully layered over top of a second solvent. These two solvents should
be miscible in one another.107 The compound should be soluble in one of them, but
not the other one. The compound precipitates along with the diffusion of two solvents.
Rate of crystal growth depends on the concentration and solubility of the compound
in the resulting mixed solvent system.
Figure 23: Crystal growth: solvent layering. Light blue: precipitating
reagent; dark blue: solution of compound.
9.3. Vapor diffusion
Vapor diffusion may succeed when other crystallization techniques fail.107 With this
method, the suitable solvent and precipitating reagent are isolated. The vapor of the
precipitating reagent diffuses into the solution so that the solubility of target
compounds decreases. The crystals ultimately precipitate from a saturated solution.
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This technique is easier to handle, and there are more options of solvents (Figure
24).95
Figure 24: Crystal growth: vapor diffusion. Light blue: precipitating
reagent; dark blue: solution of compound.
In order to harvest the crystals easily out of the containers, small vials with straight
walls are always used to allow crystals floating out without obstacle.109 All the crystal
growth experiments should be conducted without disturbance to the setups containing
crystal mother liquor.
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Part III
Result and discussion
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10. Syntheses
10.1. Synthesis of 9,9’-dimethylene-bis(adenine) 2 (AdC2Ad)
Adenine 1 was N-alkylated with 1,2-dibromoethane in the presence of NaH or K2CO3
using DMF as the solvent to give compound 2 (Scheme 5).81,82
Scheme 5
The reaction ran for 48 hours at ambient temperature, but the conversion was low.
Compound 2 was purified by recrystallization from acetic acid-methanol (1:1). The
yield was 15 % with NaH. In contrast, the yield reached 27 % when K2CO3 was
applied. In the literature there was no reported yield of final pure compound because
the crude product was split into portions for different purification methods. 81, 82
Based on the experimental result, K2CO3 was a better base than NaH for the
deprotonation of N9 position of adenine in this reaction.
For adenine N9-alkylation with 1,2-dibromoethane, under basic condition and in
solvent DMF,77, 79 the reaction is likely to follow SN2 substitution mechanism. The
adenine anion, as the nucleophile, attack from the backside of the target carbon
(Scheme 6). However, during the second step, because of the steric hindrance of the
attached adenine group, the approach of the second adenine might be very difficult.
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Scheme 6: Supposed mechanism of the synthesis of 9,9’-dimethylene-
bis(adenine) 2.
10.2. Synthesis of 9,9 '-trimethylene-bis(adenine) 3 (AdC3Ad)
Adenine 1 was N-alkylated with 1,3-dibromopropane in the presence of NaH in DMF
to form compound 3 (Scheme 7).81
Scheme 7
The reaction ran for six days at room temperature, and the conversion was still low.
The final yield of 3 was 26 % by recrystallization from acetic acid-methanol (1:1). No
literature yield of pure product was reported.81 The yield was better than that of
compound 2 which was obtained through the same route following the same
mechanism, but with a one carbon atom shorter alkyl bromide. Longer carbon chain
might reduce the steric effect of the adenine group attached in first step when the
second one approaching. The SN2 reaction is more favorable.
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10.3. Synthesis of pentaerythrityl bromide 6
The tetraol 4 was reacted with benzenesulfonyl chloride in pyridine in an
esterification reaction, and then the resulting compound 5 was reacted with NaBr to
give the final product 6 (Scheme 8). 112
Scheme 8
The first step completed after 4.5 hours at 40 oC. Compound 5 was not stable enough
for storage at room temperature, so it should be freshly prepared as an intermediate
reagent for the next step. The second step finished after 19 hours at 130 oC. The yield
of product over two steps 6 was 84 % calculated from the starting tetraol 4, and the
pure compound was obtained after washing with water and methanol.
10.4. Synthesis of pentaerythrityl iodide 7
Pentaerythrityl iodide 7 was converted from pentaerythrityl bromide 6 in a halogen
replacement reaction in the presence of NaI and methyl ethyl ketone as the solvent
(Scheme 9).113
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Scheme 9
This reaction was refluxed for four days, and the starting material was completely
consumed, but there was still incompletely substituted by-product 7a (ca. 15 % from
1H NMR spectrum of crude product). The crude product, a mixture of 7 and 7a, had
low solubility in chloroform, EtOAc, DMSO, benzene and toluene, and as both
compounds 7 and 7a have the quite similar chemical properties and polarities, it
turned out to be very difficult to separate them by recrystallization and flash
chromatography. When taking the crude mixture into a cycle as starting material to
react with excess sodium iodide for three times, the pure compound 7 was obtained
with an overall yield of 91 %.
10.5. Attempted synthesis of tetrakis(9-adeninylmethyl)methane 8
Adenine 1 reacted with pentaerythrityl tetrabromide 6 in the presence of potassium
carbonate, and DMF was used as solvent (Scheme 10). This reaction did not give the
target compound 8. Instead, monosubstituted compound 8a was detected by 1H NMR
and MS, and the conversion of adenine was very low even with heating and using of
long reaction time (Table 2).
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Scheme 10
Compared with neopentyl bromide, the structure of pentaerythrityl tetrabromide is
even more crowded (Figure 25). It is well known that primary alkyl halides usually
undergo the SN2 reaction, and SN2 reaction is sensitive to steric hindrance. Neopentyl
halide, because of its steric bulk on α-carbon, is inert towards the SN2 mechanism, but
is moderately reactive under conditions favorable to the SN1 mechanism.114 In
comparison, compound 6 is more likely followed the SN1 substitution mechanism
(Scheme 11).
Figure 25: Molecular structures of neopentyl bromide and pentaerythrityl
tetrabromide indicate the reaction centre α carbon and the steric effect
from β position.
α
β
α
β
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Scheme 11: A supposed four-step procedure of tetra substitution from
compound 6 to 8. The carbocation formed in each step.
For SN1 reactions, I- is a better leaving group than Br-, so pentaerythrityl iodide 7 was
attempted for this synthetic route while heating up to 70 oC, 100 oC and 130 oC for
two or three weeks (Table 2). Unfortunately, none of the reactions give the target
tetrasubstituted product. Signals of monosubstituted product were observed in 1H
NMR and MS (EI) spectra.
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Table 2: various conditions for synthesis of tetrakis(9-adeninylmethyl)methane
Base Temp. Time Result
12 eq. K2CO3
6
r.t. 2 weeks
70
o
C 3 weeks 8a + unknown
12 eq. K2CO3
7
70
o
C 7 days
5 spots shown on TLC plate.
No corresponding signal of
target product in 1H NMR
and MS (EI) spectra.
100
o
C 7 days
130
o
C 12 days
With continuous heating, DMF seemed to decompose with release of dimethylamine
and CO as inferred by the smell of amine from the reaction mixture. There was no
pure product recovered from the decomposed solvent.
To modify the reaction conditions, a synthesis reactor Monowave 300 was used for
microwave reaction, and DMF was changed to degassed acetonitrile to fit microwave
condition (Scheme 12). Microwave condition can provide rapid and uniform heating
for a reaction.
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Scheme 12
Under microwave condition, only potassium adenine salt 8b might be formed
according to 1H NMR and MS data after heating up to 175oC for six hours (Table 3).
This might be because the solubility of tetra iodide 7 in acetonitrile is too low to
permit the reaction at a measurable rate.
Table 3: Microwave reactions
Base Temp. Heating time Result
12 eq. K2CO3
Microwave
175
o
C
3 h
8b
5 h
6 h
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From these two synthetic methods we assumed that harsher conditions might be
needed for this transformation. Since similar N-alkylation with imidazole has been
reported, this literature route was attempted for adenine (Scheme 13).112 Strong base
NaOH and solvent mixture of DMSO and toluene were applied. The ratio between
DMSO and toluene was adjusted to 2:1 in order to completely dissolve adenine.
S
cheme 13
The reaction was run for 4 h at 120 oC, but the conversion was low and no formation
of target product 8 was observed.
10.6. Synthesis of 1,1’- trimethylene-bis(thymine) 11 (ThC3Th)
Thymine 9 was reacted with TMS-Cl and triethylamine in toluene to introduce
protecting groups at thymine O2 and O4 positions. This protecting reaction gave
intermediate O,O’-bis(trimethylsilyl)thymine 10, which is not stable at room
temperature, so it was freshly prepared and used in the next step (Scheme 14).83
Compound 10 was converted to 1,1’-trimethylene-bis(thymine) 11 when supplied
with 1,3-dibromopropane in DMF. The reaction was run for 24 h at 170 oC (Scheme
14). 83
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Scheme 14
Pure product 11 was obtained after filtration and washing with chloroform-methanol
(1:1, 100 mL). Calculated from thymine 9, the overall yield was 38 % less than the
literature yield of 75%. The loss might occur in first step. TMS-Cl was considerably
not freshly distilled, so the overall yield might be influenced. The literature reaction
time of second step was ‘overnight’. However, in our lab environment, the reaction
did not reach the full conversion even after 24 h.
10.7. Synthesis of 1,1’- dimethylene-bis(thymine) 12 (ThC2Th)
Similar to the synthesis of 1,1’- trimethylene-bis(thymine), thymine was first
converted to intermediate 10. Then 1,2-dibromoethane was added to the solution of
compound 10 in anhydrous DMF to give 1,1’- dimethylene-bis(thymine) 12 (Scheme
15).83 This reaction was run for 36 hours at 170 oC. This N1-alkylation of thymine
prefered to follow the SN2 mechanism, so it was sensetive to steric effects. For the
same reason as the N9-alkylation of adenine, short alkane chain allowed severer steric
hindrance from the attached thymine group. Hence the disubstitution rate of 1,2-
dibromoethane was lower than that of 1,3-dibromopropane.
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Scheme 15
The same purification method as for compound 11 worked well here. Based on the
amount of thymine, the overall yield of product 12 was 50 %.
10.8. Attempted synthesis of tetrakis(1-thyminylmethyl)methane 13
According to the syntheses of 1,1’- trimethylene-bis(thymine) and tetrakis(9-
adeninylmethyl)methane, thymine was firstly protected with triethylamine and TMS-
Cl to form the intermediate O,O’-bis(trimethylsilyl)thymine 10, which was treated
with reagent 7 in anhydrous DMF for N-alkylation (Scheme 16).83 For the same
reason as for adenine, this reaction was considered to follow the SN1 mechanism with
low reactivity. 42
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Scheme 16
The reaction was run for eight days, but the conversion was still low. Four products
were observed from TLC plate, and the crude product (68 mg) was applied to flash
chromatography. The major fraction eluting from the column was iodine, and it partly
sublimated into the rotavapor. The other fractions containing only one spot were too
small for the structures to be confirmed (Table 4). From the 1H NMR spectrum of the
crude product, there was no corresponding signal of target compound 13.
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Table 4: result of flash chromatography
68 mg of material was applied onto the column
Eluent :
MeOH in DCM
Fractions
# of spots on
TLC plate
Weight
1 %
1-26 No UV visible spot 21 mg*
28-34 1 <1 mg
35-41 2 <1 mg
3 %
42-47 3 <1 mg
50-55 2 <1 mg
57-61 1 <1 mg
5 %
63-70 2 ca.2 mg
71-74 - -
10 %
75-78 - -
79-87 1 <1 mg
88-93 - -
* 21 mg iodine collected after the column.
10.9. Synthesis of 1,3,5,7-tetrabromoadamantane 15
Both AlCl3 and AlBr3 can be used as Lewis acid in the halogenation reaction of
adamantane 14 and bromine (Scheme 17).115 When using AlCl3, there was always
around 5 % of 1-chloro-3,5,7-tribromoadamantane 15a in the main product 1,3,5,7-
tetrabromoadamantane 15. When AlBr3 was applied, compound 15 was the only
product, and the yield reached 91 %.
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Scheme 17
10.10. Attempted synthesis of 1,3,5,7-tetraiodoadamantane 16
The halogen replacement reaction from bromide 15 to iodide 16 was reported
(Scheme 18).115
Scheme 18
In practice this reaction did not occur. One possible reason was that AlBr3 was too
sensitive to the moisture, so that the visible orange smoke was immediately observed
while opening the reagent bottle. As a Lewis acid, AlBr3 reduced the reactivity once it
absorbed moisture, especially when used in a small scale. To avoid the exposure to
the air, AlBr3 can be handled in glove box.
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10.11. Attempted synthesis of 1,3,5,7-tetrathymineadamantane 17
The synthesis of 1,3,5,7-tetrauraciladamantane has been reported.116 Since thymine 9
and uracil have similar molecular structures and chemical properties for N-alkylation,
we applied this route to thymine (Scheme 19). Unfortunately, in the original paper
there was some conflicting information regarding the reaction temperature, which was
stated to be both 60 oC and 160 oC. Both temperatures were tried independently.
Scheme 19
This reaction was run for 48 hours at 60 oC and 24 h at 160 oC, but did not reach full
conversion. From the 1H NMR and MS spectra of the crude product, there was no
signal or fragment that indicates the target compound 17. Because of the three-
dimensional structure of adamantane, the substituent cannot attack from the backside
of bromine. In a SN1 reaction, the strain at bridgehead carbon of adamantane restrains
the formation of the planar carbocation intermediate at bridgehead position, so it
makes this alkylation reaction difficult to realize.117
10.12. Synthesis of 1,3,5,7-tetrauraciladamantane 19
Aiming at finding out any reason why the reported route failed when applied to
thymine, we repeated the exact literature reaction with uracil 18 (Scheme 20).116
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Scheme 20
Attempts were made at both 60oC and 160oC for 24 h, but neither reaction reached
full conversion, nor gave the target product 19 compared to the literature data. We
could not establish why the literature reaction was failed to work, but it was obvious
that this alkylation with adamantane is difficult.
Regarding the structure of adamantane, this substitution should follow the SN1
mechanism. As mentioned above, due to the rigid molecular structure, even SN1 is
difficult to realize. Based on the other N-alkylation reactions with adenine 1 and
thymine 9, thymine appeared to be more reactive than adenine.
Since the thymine N-alkylation with halogenated adamantane proved to be difficult,
an alternative tetrahedral molecule, tetrakis(4-(bromomethyl)phenyl)methane 21 was
attempted for N-alkylation of adenine and thymine to give node materials.
10.13. Synthesis of tetrakis(4-(bromomethyl)phenyl)methane 21
The halogenations of the commercially available starting material tetraphenylmethane
20 has been realized with bromomethoxymethane and TiBr4 as the Lewis acid to give
the target compound tetrakis(4-(bromomethyl)phenyl)methane 21 with a reported
yield of 60 % (Scheme 22). 118 The product was purified by column chromatography.
In our case, the purification was simplified by recrystallization from dichloromethane,
although the yield was a little lower as 58 %.
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Schem
e 22
Similar to AlBr3, the Lewis acid TiBr4 is also very sensitive to moisture. The emitted
orange smoke can be observed once the reagent bottle is opened. To avoid the loss of
reactivity, the reaction should be carried out in a relatively large scale and with
substantial excess of TiBr4. Alternatively, a glove box could be used to handle this
chemical. In our case, the reaction was in a large scale.
10.14. Synthesis of tetrakis(4-thyminylmethylphenyl)methane 22 (Th4)
From previous reactions it turned out that silylated thymine 10 could be completely
dissolved in DMF, while unprotected thymine 9 existed in suspension form in the
same amount of DMF. Considering their solubility, we designed the synthetic strategy
described in Scheme 23 according to the route for synthesis of 1,1’- dimethylene-
bis(thymine) 12 using protected thymine.
Scheme 23
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Since the aromatic ring system helped to stabilize the carbocation as described above,
this reaction provided a promising result. The structure of novel compound 22 was
confirmed by 1H NMR, 13C NMR, MS (ESI) and single crystal X-ray diffraction.
Although the yield (49 %) was not high, it was acceptable. The crowded molecular
structure indicated a reason why this reaction required much heating and long time.
This compound has high polarity and poor solubility. Hence the purification was
reasonably challenging.
10.15. Synthesis of tetrakis(4-adeninylmethylphenyl)methane 23 (Ad4)
The strategy for synthesis of tetrakis(4-adeninylmethylphenyl)methane 23 was
proposed in the light of route for 9,9’- dimethylene-bis(adenine) 2 synthesis (Scheme
24).
Scheme 24
This novel compound was confirmed by 1H NMR, 13C NMR and MS (ESI). Due to
the poor solubility and high polarity of each component in the crude product, the
purification turned out to be challenging. Based on the TLC plate, there was a serious
trailing phenomenon. Flash chromatography was utilized with an eluent system of
5 % MeOH saturated with NH3 in DCM. The use of NH3 aimed to improve the
trailing. After twice of flash chromatography, the purity was enhanced to 93%.
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Unfortunately, during the third time of purification, a large amount of silicone grease
was introduced from external environment by mistake, so the product was
contaminated.
11. Crystal growth
11.1. Choice of solvent and precipitating reagent
For all the linker materials, AdC2Ad (2), AdC3Ad (3), ThC2Th (11) and ThC3Th
(12), and the node compound Th4 (22), considerable effort was put into the testing of
solubilities in common solvents ranging from organic to inorganic, from low polarity
to high polarity. DMSO, DMF, MeOH, MeCN, H2O, 2-propanol (IPA), 1,1,1,3,3,3-
hexafluoro-2-propanol (HFP) and DCM were tried. HFP was the only one which
could dissolve all the compounds at room temperature, even though it took about 10
minutes before the solution of AdC2Ad (2) became clear. In DMSO, much heating
was needed to achieve limited solubility. Linker compounds AdC2Ad (2) and
AdC3Ad (3) had lower but little different solubility than linker ThC2Th (11) and
ThC3Th (12), but much lower solubility than node compound Th4 (22) under the
same conditions. For the other solvents, the solubility of all the compounds was
extremely low. Interestingly, the Th4 node compound could be completely dissolved
in a solvent mixture of MeOH-DCM, but not any of the linker compounds. For crystal
growth experiments with vapor diffusion technique, a range of precipitating reagents,
including DCM, MeOH, MeCN, H2O, EtOAc and IPA, were attempted with the
linker and node compounds.
11.2. Crystal formation
The crystal growing procedures showed that in most of setups containing mixed
materials, two compounds always precipitated from the solution separately and in
different shapes (Table 5). The solvent system of MeOH-DCM was tested for Th4
crystal growth.
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Table 5: Results of crystallization experiments
Materials Methods Results
Th4
HFP
Slow evaporation
Long needle-shaped crystals
Th4
DMSO
Slow evaporation
Needle-shaped crystals
Th4
MeOH&DCM-MeCN
Vapor diffusion
Amorphous powder
Th4-AdC2Ad
HFP
Slow evaporation
Needle-shaped crystals
Th4-AdC2Ad
HFP-EtOAc
Vapor diffusion
Beads
Th4-AdC2Ad
HFP-MeOH
Vapor diffusion
Needle-shaped crystals and beads*
Th4-AdC2Ad
HFP-DCM
Vapor diffusion
Plate-shaped crystals*
Th4-AdC2Ad
HFP-MeCN
Vapor diffusion
Beads
Th4-AdC2Ad
HFP-H2O
Vapor diffusion
Tiny crystals and beads
Th4-AdC3Ad
HFP-MeOH
Vapor diffusion
Needle-shaped crystals and beads
Th4-AdC3Ad
HFP-DCM
Vapor diffusion
Plate crystals
Th4-AdC3Ad
HFP-IPA
Vapor diffusion
Needle-shaped crystals and beads*
Th4-AdC3Ad
HFP-H2O
Vapor diffusion
Tiny crystals and beads
Th4-AdC3Ad
HFP-MeCN
Vapor diffusion
Beads
Note: 1) * From this experiment, crystal was picked for single crystal XRD data collection. 2) Beads
indicate the ball-shaped non-crystalline powder with the size < 0.1mm.
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The node compound Th4 (22) was crystallized from both DMSO and HFP separately.
Long, thin needle-shaped colorless crystals were observed from HFP (Picture 1),
while small needle-shaped crystals formed from DMSO.
Picture 1: Long, thin needle-shaped crystals sticked to the wall of the vial.
For most of the experiments containing two compounds, crystals and beads forming
in different rates were visible. A general appearance is shown as Picture 2.
Picture 2: Small beads stick on the wall and the crystals lie at the bottom
of the vial.
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A possible explanation for this phenomenon was based on the solubility. When two
compounds have quite different solubilities in a solvent, the less soluble one reached
the saturation concentration earlier than the other one, so they precipitated after quite
different periods. In this occasion it was not prospective to form complex of these two
compounds, and this was confirmed by single crystal XRD tests.
11.3. Stability
As indicated in Table 5, we managed to harvest some promising crystals for single
crystal XRD experiments. The needle-shaped crystals from Th4-AdC3Ad in HFP-
MeOH system were unstable after being removed from the mother liquor evidently
due to the loss of co-crystallized solvent as were the crystals from Th4-AdC3Ad in
HFP-IPA system. Hence, flash freezing in liquid nitrogen was used to stabilize the
crystals before being transferred to the cold stream on the diffract meter for data
collection at 100K. The plate crystal from Th4-AdC2Ad in HFP-DCM system was
stable enough at room temperature without any special treatment.
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12. X-ray diffraction experiments
12.1. Powder XRD attempts with linker materials only
To explore any possibility of combination between two types of linker molecules,
ThC2Th 12 and AdC2Ad 2, several treatment methods were tried as in Table 6.
Table 6: Attempts for forming the complex of ThC2Th and AdC2Ad
Material Treatment Result
ThC2Th - Reference (Figure A1)
AdC2Ad - Reference (Figure A2)
ThC2Th~AdC2Ad
HFP-MeOH
Vapor diffusion
No complex (Figure A3)
ThC2Th~AdC2Ad Grind in H2O No complex (Figure A4)
ThC2Th~AdC2Ad Grind in DMSO No complex (Figure A5)
ThC2Th~AdC2Ad Grind in toluene No complex (Figure A6)
ThC2Th~AdC2Ad Grind in acetic acid No complex (Figure A7)
ThC2Th~AdC2Ad Ultrasonic, 5h, DMSO No complex (Figure A8)
ThC2Th~AdC2Ad Ultrasonic, 5h,H2O No complex (Figure A9)
ThC2Th~AdC2Ad Ultrasonic, 5h, toluene No complex (Figure A10)
ThC2Th~AdC2Ad 210 oC, 5 min No complex (Figure A11)
ThC2Th~AdC2Ad 250 oC No complex (Figure A12)
ThC2Th~AdC2Ad 300 oC No complex (Figure A13)
ThC2Th~AdC2Ad 350 oC
Color change
Decomposed (Figure A14)
Note: Figure A1-A14 corresponding to powder XRD patterns are shown in Appendix.
Compared to the PXRD spectra of ThC2Th (12) AdC2Ad (2), in Figure A3- A14
there was no any new signal indicating the formation of aimed complex of ThC2Th
and AdC2Ad. It might because the intermolecular H-bonds of each compound might
be so strong that they could not be broken even with molecular environment or
thermodynamics intervention. Since ThC3Th has similar structure and solubility with
ThC2Th, and AdC3Ad is similar to AdC2Ad, it was not essential to try the same
experiments for them.
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12.2. Single crystal XRD
12.2.1. Crystal from Th4-AdC3Ad in HFP-MeOH system
The structure was solved and refined with SHELXL-2013 to give the information in
Table 7. The diffuse electron density from unidentified, disordered solvent molecules
was initially refined to an R-factor of 0.1503. All solvent atoms were subsequently
removed from the model, with electron density within the resulting void being
efficiently removed by the SQEEZE routine of the PLATON program. Based on the
new, corrected diffraction data file output from SQEEZE, further structural
refinement brought the final R-factor down to 0.0727.
The XRD data defined this crystal as a crystalline framework of node compound Th4
(Figure 26). The framework was assembled via H-bonds. An asymmetric unit
contains two Th4 molecules and one methanol molecule.
Figure 26: Two independent Th4 (22) molecules and one MeOH
molecule in the asymmitric unit of –x,-y,-z. Thermal displacement
ellipsoids are shown at the 50 % probability level.
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Figure 27: The hydrogen bonding sites of each Th4 (22) molecule are
labeled. Hydrogen bonds are shown as dashed lines.
In a hydrogen bonding pattern (Figure 27), molecule A (right) bonds to this MeOH
molecule via one hydrogen bond. Three side-chains of this molecule connect to
adjacent one through one hydrogen bond, while the other side-chain forms three
hydrogen bonds. In molecule B (left), two of its side-chains have three binding site
and the other two have only one. It is noticeable that O8B as an acceptor forms two
hydrogen bonds at one site. The crystal packing form of Th4 is shown in Figure 28.
63
Figure 28: Crystal packing form of Th4 (22) viewed along the a axis.
Hydrogen bonds are shown as dashed lines.
Figure 29: Crystal packing form of Th4 (22) viewed along the a axis. The
void space after removing all the disordered solvent molecules was
calculated by Mercury using a 1.2 Å probe radius and 0.5 Å grid spacing.
The void surface is colored yellow
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Channel system in this type of framework is two-dimensional, and the void volume
after removal of disordered solvent molecules was calculated to 2086 Å3 by SQEEZE,
accounting for 35 % of the unit cell volume (Figure 29). When rotating the crystal
packing form along the axis vertical to bc plane, we can see how the 2D channels
exist (Figure 30).
Figure 30: Rotation of crystal packing form of Th4 (22) from (a) viewed
along b axis, to (b) paralleled 2D channels, to (c) opposite view of (a), to
(d)
(a) (b)
(c)(d)
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Table 7: XRD data of Th4 crystal from HFP-MeOH
Crystal data
Chemical formula C49H44N8O8
Mr 872.94
Space group Triclinic
P-1
Cell a = 14.4613(17) Å α = 65.194(3)
b = 20.326(2) Å β = 85.341(3)
c = 23.303(2) Å γ = 73.765(3)
V (Å3) 5964.7(12)
Solvent Accessible Volume (Å3) 2085.3
Z 8
Radiation Mo Kα
wavelength 0.71073
μ (mm-1) 0.069
Temperature (K) 100
Data collection
Tmin, Tmax 0.742, 0.998
Measured reflections 88019
Independent reflections 16010
Reflections with I > 2σ(I) 10446
Rint 0.0727
Refinement
R[F2 > 2σ(F2)] 0.0727
wR(F2) 0.1814
No. of reflections 16010
No. of parameters 1201
Δρmax,
Δρmin
0.597
-0.279
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12.2.2. Crystal from Th4-AdC3Ad in HFP-DCM system
The structure was solved and refined with SHELXL-2014 to give the information in
Table 8. This crystal was confirmed as a crystalline framework of linker compound
AdC2Ad with participation of four times of solvent (HFP) molecules (Figure 31).
The framework was assembled via H-bonds described in List 2.
O1C
N3A
N4A
H31A
H1C
N2A
H1B
O1B
N1A C1A
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Figure 31: The molecular structure of AdC2Ad tetrahexafluoro -2-
propanol solvate. Thermal displacement ellipsoids are shown at the 50 %
probability level. The right half of the AdC2Ad molecule (atoms in lighter
color) is generated from the left part by center-of-symmetry (small circle
with yellow fill) with code –x +1, y, –z + 1.
The symmetric molecules assembled into a crystal network via hydrogen bonds with
HFP solvent molecules as a part of building unit (Figure 32).
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Figure 32: Crystal packing viewed along the a axis. Dashed lines:
hydrogen bondS.
Figure 33: Hydrogen-bonded tape motif of AdC2Ad molecules supported
by the solvent molecules. O1C acts as both a donor and an acceptor, while
O1B is less tightly bound and acts only as a donor to N2A.
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The AdC2Ad molecules are connected by a N1A...H32A-N3A (–x +1, y, –z + 1)
hydrogen bonded tape (Figure 33). HFP molecules paticipate a N1A…H32A-N3A-
H31A…O1C hydrogen donded chain in this framework. Considering the high solvent
content in these crystals, it is remarkable that they are stable at room temperature.
This framework is a densely packed structure of stacked layers, and there is no a
channel or pore through this network. The layer can be described as a sandwich form,
for which the solvent molecules act as ‘bread’ and AdC2Ad molecules is the filling.
Figure 34: Stacking of hydrogen-bonded tapes along the ab-diagonal.
c
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Table 8: XRD data of type AdC2Ad crystalline network
Crystal data
Chemical formula C12H12N10
Mr 296.30
Space group Triclinic
P-1
Cell a = 7.1752(7) Å α = 86.613(2)
b = 10.3078(10) Å β = 87.488(2)
c = 12.3995(12) Å γ = 71.906(2)
V (Å3) 869.89(15)
Solvent Accessible Volume (Å3) 1
Z Mo Kα
Radiation 0.71073
wavelength 0.213
μ (mm-1) 100
Temperature (K)
Data collection 0.994, 0.997
Tmin, Tmax 21096
Measured reflections 4878
Independent reflections 3936
Reflections with I > 2σ(I) 0.0281
Rint
Refinement 0.0365
R[F2 > 2σ(F2)] 0.0818
wR(F2) 4878
No. of reflections 319
No. of parameters
Δρmax,
Δρmin
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12.2.3. Crystal from Th4-AdC2Ad in HFP- IPA system
The structure was solved and refined with SHELXL-2013 to give the information in
List 3. Electron density from disordered solvent molecules was first refined to an R-
factor of 0.1335. All solvent atoms were subsequently removed from the model by the
SQEEZE routine of the PLATON program. Based on the new, corrected diffraction
data file output from SQEEZE, further structural refinement brought the final R-factor
down to 0.0796.
The result showed this crystal was also a crystalline framework of node compound
Th4 with presence of solvent molecules (Figure 35). The framework was assembled
via H-bonds described in Table 9.
Figure 35: The molecular structure of Th4 (22) with the atomic
numbering. Thermal displacement ellipsoids are shown at the 50 %
probability level.
This compound forms the framework by intermolecular hydrogen bonds (Figure 36).
Due to the overlay of atoms in one side-chain, a rotated view of this part is provided
to the top right.
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Figure 36: The hydrogen bonding sites of Th4 (22) molecule are labeled.
Hydrogen bonds are shown as dashed lines.
Each Th4 molecule connects to the adjacent one via hydrogen bonds. In three side-
chains, two hydrogen bonds present into a tape for each of them, while for the fourth
arm, only one hydrogen bond forms to link two molecules. The two hydrogen bonds
establish an eight number ring system with less flexibility than single bond. In this
way, the molecules pack into a 3D framework with an unusual large void, which
stabilized by numerous solvent molecules (Figure 37, 38).
Figure 37: Crystal packing form of Th4 (22) viewed along the b axis
without showing thehydrogen bonds.
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Figure 38: Crystal packing of Th4 (22) viewed along the b axis showing
the void volume after removal of solvent molecules, as calculated by
Mercury using a 1.2 Å probe radius and 0.5 Å grid spacing.
To view observe the three dimensional structure of the channels, an illustration shows
the slices of a channel (Figure 39). Cuts was made at 3 Å intervals. The c axis is
approximately 15 Å, so after five steps the cycle repeated as shown. From above
figures three-dimensional channel can been seen extending throughout the whole
network. According to the calculation by Mercury, channels account for 46 % of unit
cell volume was channel.
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Figure 39: A series of five 5 Å thick slices of the crystal structure of Th4
viewed along the c axis. They illustrate the extended system of channels.
1 2
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Table 9: XRD data of type B Th4 crystalline network
Crystal data
Chemical formula C49H44N8O8
Mr 872.94
Space group Monoclinic
P 21/c
Cell a = 14.9614(17) α = 90
b = 15.2536(16) β = 96.288(3)
c = 30.990(4) γ = 90
V (Å3) 7029.9(14)
Solvent Accessible Volume (Å3) 3306.5
Z 4
Radiation Mo Kα
wavelength 0.71073
μ (mm-1) 0.057
Temperature (K) 100
Data collection
Tmin, Tmax 0.742, 0.998
Measured reflections 88019
Independent reflections 16010
Reflections with I > 2σ(I) 10446
Rint 0.0727
Refinement
R[F2 > 2σ(F2)] 0.0727
wR(F2) 0.1814
No. of reflections 16010
No. of parameters 1201
Δρmax,
Δρmin
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13. Conclusion
Comparison of two types of Th4 crystalline networks
It was noticeable that the same compound Th4 gave two crystal forms from different
solvent systems by the same method. Viewing the modeling structures, the difference
of phenyl ring and thymine ring orientations could be noticed (Figure 40).
Figure 40: (a) The molecular overlay view of crystal from HFP-
MeOH system. Orange: molecule A; Green: molecule B. (b) The
molecular structure from HFP-IPA system.
This specificity might be a result of by the flexibility at -CH2- positions which
allowed the thymine arms to extend into several possible directions, especially in the
presence of typical solvent effect via H-bonds.
The crystalline network with such a large void space filling with solvent molecules is
highly unusual. Another feature of Th4 (22) is that these two types of crystalline
networks exist respectively in 2D and 3D forms.
(a) (b)
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14. Future work
Considering two structures of Th4 (22) crystals, single hydrogen bond between
thymine groups formed in both crystals. For a rigid network, a multiple hydrogen
bond between nucleobases is more favorable to restrict the flexibility of the whole
structure. In natrual DNA double helix, guanine and cytosine connect through three
hydrogen bonds when adenine and thymine have two in between. Herein, the pair of
guanine and cytosine may provide more opportunities to obtain a porous framework
assembled via multiple hydrogen bonds. Although we mentioned that the syntheses of
these two nucleobases derivatives may require more protecting and deprotecting
reactions, it is worth attempts.
14.1. Design of node compounds
To avoid the flexibility in the molecular structure like in node compound Th4 (22),
and also considering about the difficulties towards synthesis, there are some
candidates suggested in Figure 41.
Figure 41: Two possible structures of novel node materials derived
from tetra p-bromophenyl methane and adamantane.
Here, the ‘Base’ includes adenine, thymine, guanine and cytosine. These designed
structures are all tetrahedral, which allow constructing 3D configurations.
Regarding (a) and (b), the nucleobase group directly connects to a phenyl derivative.
This may be realized by N-arylation reaction with possible selectivity. A general
approach to N-arylation of all four DNA nucleobases is undergoing the copper-
mediated Chan-Lam-Evans-modified Ullmann condensation with a range of different
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substituted phenyl boronic acids at room temperature.119 Protected or masked
nucleobases are required and would be subsequently converted back to the
corresponding deprotected or unmasked adducts (Scheme 25).120-122
Scheme 25: General strategy for the N-Arylation of nucleobases.119
In the literature, they reported various aryl R groups. The lowest yield (40%) of a
final product was observed for guanine N-arylation.
Substituted phenyl boronic acids corresponding to (a) and (b) should be tetra(4-
dihydroxyborylphenyl) adamantane 24 and tetra(4-dihydroxyborylphenyl) methane 25
(Figure 42). Compound 25 is well known as a common building unit material for
COFs.32, 37 Adamantane derivatives were reported to follow the same synthetic routes
in typical cross-coupling reactions.123 Hence, all the essential materials for syntheses
of (a) and (b) should be available. Similar to the prepared node compounds 22 and 23,
molecule (a) or (b) also contains four nucleobase groups, which may lead to a low
solubility in common used solvents.
Figure 42: Strcutures of tetra(4-dihydroxyborylphenyl) adamantane
and tetra(4-dihydroxyborylphenyl) methane
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14.2. Options of linker materials
During the project, a key issue is about the solubility. The big gap between the
solubilities of linker and node compounds is the main reason why these two materials
precipitated separately from the solution so that the combination did not achieved. For
this problem, the follwing alternatives can be regarded as linker options (Figure 43).
Figure 43: Four prospective structures of novel linker materials
derived from benzene and biphenyl.
Here, the ‘DNA base’ extended to all four nucleobases. The compounds (a) and (b)
have been prepared using 6-chloropurine as the starting material combined with
amination at 6- position.124 Syntheses of compounds (c) and (d) may undergo the
same routes as that of designed node compounds (a) and (b). Regarding these
structures, the N-arylation for linkers could be even faster with a higher yield than the
reaction for synthesis of nodes. All the teactants are commertially or synthetically
available.
All these candidates contain at least one benzene ring, and each of our node
compounds Th4 22 and Ad4 23 have four benzene ring in their structure. In this way,
the node and linker materials own some chemical similarities, especially for (a) and (b)
with additional methylene groups. Similar molecular structures always have similar
solubilities. In this case, the target molecules may contribute to reducing the solubility
gap between linker and node, so there can be more significant possibility to form the
complex of linker and node.
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Part IV
Experimental
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1H NMR spectra were recorded at 600 MHz with a Bruker AV 600 instrument, at 400
MHz with a Bruker AVII 400 instrument, at 300 MHz with a Bruker DPX 300 or at
200 MHz with a Bruker DPX 200 instrument. The decoupled 13C NMR spectra were
recorded at 150, 100 or 75 MHz using instruments mentioned above. All J values are
reported in Hertz. Mass spectra (EI) were recorded on a VG Prospec sector instrument
at 70 eV ionizing voltage and presented as m/z (% rel. int.), while HRMS was
performed with a double-focusing magnetic sector instrument. Electrospray mass (ESI)
spectra were obtained on a Micromass QTOF II spectrometer. Melting points were
determined with Büchi melting point B-545 apparatus and are uncorrected. Single-
crystal X-ray crystallography was performed with a Bruker D8 venture diffractometer
with MoKα irradiation at temperature of 100 K. Powder XRD spectra were recorded
at Bruker D8 discover instrument at room temperature with scan scale from 2 to 90 or
60 degrees. Ultrasonic experiments were done with a VWR Ultrasonic cleaner
instrument. Microwave experiments were conducted in sealed vessels in a synthesis
reactor Monowave 300, Anton Paar GmbH, equipped with an internal IR probe.
Dry DMF, MeCN and CH2Cl2 were obtained from a MB SPS-800 solvent purification
system. Benzenesulfonyl chloride was distilled under reduced pressure. Hexane was
fresh distilled before using. TMSCl was distillated over CaH2. Triethylamine was
dried over KOH. Toluene was dried over sodium. Acetonitrile for microwave reaction
was degassed by using the freeze-pump-thaw method with three cycles in liquid N2.
Other reagents were commercially available and used as received. Sodium iodide was
dried at 120 oC under high vacuum overnight.
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15. Syntheses
15.1. 9,9’-Dimethylene-bis(adenine) 2.
Method A:
Adenine 1 (1.00 g, 7.40 mmol) and NaH (ca. 60 % in mineral oil, 501 mg, ca. 11.1
mmol) were added into dry DMF (30 mL) and stirred under N2 at ambient
temperature. After 1 h, 1,2-dibromoethane (1.01 g, 5.40 mmol) was added, then the
reaction mixture was stirred under N2 at ambient temperature for 48 h. After filtration,
the solid was washed with water (10 mL), acetone (10 mL) and diethyl ether (10 mL).
The crude product was crystallized from acetic acid-methanol (1:1). Yield 164 mg
(15 %) of colorless amorphous powder.
Method B:
To a mixture of adenine (1.00 g, 7.40 mmol) and potassium carbonate (1.10 g, 7.80
mmol) in DMF (30 mL), 1,2-dibromoethane (733 mg, 3.90 mmol) was added. The
mixture was stirred at ambient temperature for 60 h. The resulting mixture was
filtrated and washed with water (10 mL), acetone (10 mL) and diethyl ether (10 mL)
to give the crude product. Then the crude product was recrystallized from acetic acid-
methanol (1:1). Yield 296 mg (27 %).
M.p. > 400 oC (Lit.81 > 335 oC ).
1H NMR (TFA-d1, 400 MHz): δ 8.82 (s, 2H, Ad H2), 8.40 (s, 2H, Ad H8), 5.05 (s, 4H,
CH2).
13C NMR (TFA-d1, 100 MHz): δ 151.62 (C6), 151.41 (C2), 149.03 (C4), 147.22 (C8),
116.40 (C5), 47.39(CH2).
MS (EI): 296 (32, M+), 162 (100), 148 (10), 135 (52), 108 (22), 67 (7).
HR-MS: 296.1251, calculated for C12H12N10 296.1246.
15.2. 9,9 '-Trimethylene-bis(adenine) 3.
Adenine 1 (1.00 g, 7.40 mmol) and NaH (ca. 60 % in mineral oil, 376 mg, 9.40 mmol)
were added into dry DMF (30 mL) and stirred under N2 at ambient temperature. After
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1 h, 1,3-dibromopropane (795 mg, 3.90 mmol) was added, then the reaction mixture
was stirred under N2 at ambient temperature for 6 days. After filtration, the solid was
washed with water, acetone and diethyl ether. The crude product was crystallized
from acetic acid-methanol (1:1). Yield 295 mg (26 %) of colorless amorphous powder.
M.p. 330 oC (Lit.81 330 oC).
1H NMR (TFA-d1, 400 MHz): δ 9.37(s, 2H, Ad H2), 8.78(s, 2H, Ad H8), 4.87(t,
J=7.2 Hz, 4H, N-CH2), 2.93(quintet, J=7.2, 2H, -CH2-).
13C NMR (TFA-d1, 100 MHz): δ 151.22 (C6), 150.96 (C2), 149.50 (C4), 146.64 (C8),
115.05 (C5), 46.08 (N-CH2), 31.78 (-CH2-).
MS (EI): 310 (56, M+), 175 (52), 162 (100), 148 (49), 136 (11), 108 (8).
HR-MS: 310.1408, calculated for C13H14N10 310.1403.
15.3. Pentaerythrityl bromide 6.
Step 1:
Pentaerythritol 4 (2.73 g, 20.0 mmol) was stirred in pyridine (30 mL) at ambient
temperature until dissolved. Benzenesulfonyl chloride (21.4 g, 121 mmol) was added
dropwise during ca. 1.5 h while controling the reaction temperature below 35 oC. The
reaction mixture was stirred at 40 oC for 4.5 h, then was poured slowly to a vigorously
stirred solution of conc. hydrochloric acid (16 mL) in water (20 mL) and methanol
(40 mL). The resulting mixture was filtered, and washed with water (100 mL), and
cold methanol (2x10 mL). The crude product 5 was dried in high vacuum. Yield 12.1
g.
M.p. 102-103oC (lit.112 102-103 oC).
1H NMR (CDCl3, 200 MHz): δ 7.54-7.83 (m, 20H, Ph), 3.88 (s, 8H, CH2).
Step 2:
NaBr (10.2 g, 99.0 mmol) was added into the solution of compound 5 (7.68 g, 11.0
mmol) in diethyleneglycol (20 mL). The reaction mixture was stirred at 130 oC for 19
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h. The resulting mixture was cooled to ca. 60 oC, then rapidly added ice water (150
mL) to adjust the temperature to 10 oC. The mixture was filtered and washed with
water (3x20 mL). The final product was crystallized from cold ethanol. Yield 3.56 g
(84 %) of colorless crystalline solid corresponding to 4.
M.p. 158-159 oC (lit.113 158 -160 oC).
1H NMR (CDCl3, 200 MHz): δ 3.59 (s, CH2).
MS (EI): 388 (24, M+), 311/309/307/305 (31/99/100/33), 229/227/225 (6/15/7),
215/213/211 (7/17/8), 147/145 (17/18), 133/131 (15/11).
HR-MS: 383.7358, calculated for C5H8Br4 383.7360.
15.4. Pentaerythrityl iodide 7.
Step 1:
A mixture of pentaerythrityl bromide 6 (5.63 g, 14.5 mmol) and sodium iodide (17.4 g,
116 mmol) was stirred in ethyl methyl ketone (50 mL), and refluxed for 4 days under
N2 (g). The solvent was evaporated and the residue was washed into a Büchner funnel
with hot water. The solid was washed with boiling water and 95 % ethanol to get the
crude pentaerythrityl iodide. Yield 8.03 g of colorless crystalline crude product, and
the purity was ca. 85 % from 1H NMR integration.
Step 2:
The crude product (8.03 g) from step 1 and sodium iodide (4.35 g, 29.0 mmol) was
stirred in ethyl methyl ketone (50 mL), and refluxed for 4 days under N2 (g). The
solvent was evaporated and the residue was washed into a Büchner funnel with hot
water. The solid was washed with boiling water and 95 % ethanol to get the second
crude pentaerythrityl iodide. Then sodium iodide (2.18 g, 14.6 mmol) was added into
the second crude product while stirring in ethyl methyl ketone (50 mL), and the
resulting mixture was refluxed for 2 days under N2 (g). The solvent was evaporated
and the residue was washed into a Büchner funnel with hot water. The solid was
washed with boiling water and 95 % ethanol to get the final pure colorless crystalline
compound 7. The overall yield of 7 was 7.59 g (91 %).
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M.p. 234 oC (lit.113 233 oC).
1H NMR (CDCl3, 400 MHz): δ 3.48 (s, CH2).
MS (EI): 576 (37, M+), 449 (100), 321 (5), 254 (2), 195 (16), 67 (52).
15.5. Attempted synthesis of tetrakis(9-adeninylmethyl)methane 8.
Method A:
Adenine (305 mg, 2.20 mmol) and potassium carbonate (311 mg, 2.20 mmol) were
mixed in DMF (15 mL). After 1 h, pentaerythrityl bromide (213 mg, 0.550 mmol) or
pentaerythrityl iodide (316 mg, 0.550 mmol) was added. The mixture was stirred
under N2 and heated as corresponding temperature and time described in Table 2. The
reaction was followed by TLC. There was no workup done after DMF decomposed.
Mono substituted compound 8a was observed in reaction mixture from NMR result:
1H NMR (DMSO-d6, 200 MHz): δ 8.17 (s, 1H, Ad H2), 8.09 (s, 1H, Ad H8), 7.27 (s,
2H, Ad NH2), 4.45 (s, 2H, N-CH2), 3.72 (s, 6H, Br-CH2).
MS (EI): no molecular ion, 364/362/360 (1/3/1, M-Br+), 149/148 (3/2), 135 (4), 108
(1), 44 (100).
Method B:
Adenine (106 mg, 0.740 mmol) and potassium carbonate (205 mg, 1.50 mmol) were
mixed in degassed acetonitrile (15 mL) in a microwave vial filled with N2. The
mixture was stirred in microwave oven at 150 oC for 20 min. Pentaerythrity iodide
(53.0 mg, 0.0920 mmol) was added. The mixture was stirred at 175 oC for
corresponding time described in Table 3. The resulting mixture was filtered and
washed with water, acetone and diethyl ether. Yield 53 mg of 8b corresponding to
starting adenine.
1H NMR (DMSO-d6, 400 MHz): δ 7.81 (s, 1H, Ad H2), 7.50 (s, 1H, Ad H8), 5.70 (s,
2H, Ad NH2).
13C NMR (DMSO-d6, 100 MHz): δ 161.20 (C6), 153.73 (C2), 151.10 (C4), 147.50
(C8), 121.66 (C5).
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Method C:
Adenine 1 (135 mg, 1.00 mmol) was dissolved in mixed solvent of DMSO (15 mL)
and toluene (7.5 mL). Aq. NaOH (50 % (w/w), 80.0 mg) was added and water in
reaction mixture was removed through a Dean-Stark condenser. Compound 7 (115 mg,
0.200 mmol) was added and the mixture was stirred at 120 oC for 4 h. The resulting
mixture was filtered and the filtrate was concentrated under reduced pressure. The
crude product was recrystallized from ethanol. 2 mg of unknown product was
obtained.
15.6. 1,1’- Trimethylene-bis(thymine) 11
Step 1:
Thymine 9 (1.30 g, 10.3 mmol) was stirred in dry toluene (30 mL) while
chlorotrimethylsilane (2.55 g, 23.5 mmol) was added. Triethylamine (2.88 g, 28.5
mmol) dissolved in toluene (10 mL) was added to the reaction mixture and then
stirred for 48 h. The resulting mixture was filtered and washed with dry toluene (3x10
mL). The filtrate was concentrated under reduced pressure to give O,O’
bis(trimethylsilyl)thymine 10.
Step 2:
To the intermediate product 10 (8.31 g, 30.7 mmol) dissolved in DMF (50 mL) 1,3-
dibromopropane (3.16 g, 15.6 mmol) was added while stirring at ambient temperature.
The solution was heated up to 170 oC and stirred for 24 h. The reaction mixture was
cooled to 0 oC and MeOH (20 mL) was added while stirring. The resulting mixture
was filtered and the solid was washed with 1:1 chloroform-methanol (100 mL). Yield
2.30 g (38 %) of 11 as colorless amorphous powder.
M.p. 330-332 oC (lit.83 330-334 oC).
1H NMR (DMSO- d6, 200 MHz): δ 11.22 (s, 2H, Th H3), 7.52 (s, 2H, Th H6), 3.65 (t,
J=7.0 Hz, 4H, N-CH2), 1.89 (quintet, J=7.0 Hz, 2H, -CH2-), 1.73 (s, 6H, Th CH3).
13C NMR (DMSO- d6, 100 MHz): δ 164.23 (C4), 150.89 (C2), 141.20 (C6), 108.52
(C5), 44.81 (N-CH2), 27.86 (CH2), 11.92 (CH3).
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MS (EI): 292 (28, M+), 166 (100), 153 (38), 140 (33), 123 (9), 110 (42).
15.7. 1,1’- dimethylene-bis(thymine) 12
Step 1:
The intermediate product O,O’ bis(trimethylsilyl)thymine 10 was synthesized in the
same way as described in 15.6 Step 1.
Step 2:
1,2-dibromoethane (1.15 g, 6.10 mmol) was added to intermediate product 10 (3.29 g,
12.2 mmol) in DMF (30 mL) while stirring at ambient temperature. The solution was
heated to 170 oC and stirred for 36 h under N2 (g). The reaction mixture was cooled
to 0 oC and MeOH (10 mL) was added. The resulting mixture was filtered and the
solid was washed with 1:1 chloroform-methanol. Yield 718 mg (50 %) of 12 as
colorless amorphous powder.
M.p. >370 oC (lit.125 > 310 oC).
1H NMR (DMSO-d6, 200 MHz): δ 11.20 (s, 2H, Th H3), 7.41 (s, 2H, Th H6), 3.87 (s,
4H, CH2), 1.71 (s, 6H, Th CH3).
13C NMR (DMSO-d6, 100 MHz): δ 164.21 (C4), 151.06 (C2), 141.20 (C6), 108.62
(C5), 46.08 (CH2), 11.92 (CH3).
MS (EI): 278 (24, M+), 152 (100), 139 (10), 126 (11), 109 (37), 96 (78).
15.8. Attempted synthesis of tetrakis(1-thyminylmethyl)methane 13
Step 1:
The intermediate product O,O’ bis(trimethylsilyl)thymine 10 was synthesized in the
same way as described in 15.6 Step 1.
Step 2:
87
Pentaerythrityl iodide (115 mg, 0.200 mmol) was added into solution of silylated
thymine 10 (270 mg, 1.00 mmol) in DMF (5 mL). The mixture was stirred under N2
(g) and heated to 170 oC for 8 days. The reaction was followed by TLC. The reaction
mixture was cooled to 0 oC and methanol (10 mL) was added. The resulting mixture
was filtered and washed with 1:1 MeOH-CHCl3. Yield crude product 114 mg, and it
was applied to column, using eluent system of MeOH in DCM as described in Table 4.
15.9. 1,3,5,7-Tetrabromoadamantane 15
Method A:
A mixture of anhydrous AlCl3 (12.0 g, 90.0 mmol) and bromine (6.00 mL, 120 mol)
was cooled to 0oC. Adamantane 14 (3.00 g, 22.0 mmol) was added in portions slowly.
Evolved HBr gas was passed through a flask containing concentrated aqueous sodium
bisulfite. The mixture was refluxed for 40 h. The reaction mixture was treated first
with saturated sodium bisulfite solution (10 mL), and then with 6N HCl (10 mL). The
resulting mixture was taken into chloroform, and washed with water (2×20 mL) and
brine (20 mL). The organic phase was dried with magnesium sulfate, filtered and
concentrated under reduced pressure. The crude product was recrystallized from 1:2
acetone-water to give 8.06 g product mixture of 15 and 15a (ratio 95:5).
Method B:
A mixture of anhydrous AlBr3 (11.7 g, 44.0 mmol) and bromine (3.00 mL, 60.0 mmol)
was cooled to 0oC. Adamantane 14 (1.50 g, 11.0 mmol) was added in portions slowly.
Evolved HBr gas was passed through a flask containing concentrated aqueous sodium
bisulfite. The mixture was refluxed for 28 h. The reaction mixture was treated first
with saturated sodium bisulfite solution (10 mL), and then with 6N HCl (10 mL). The
resulting mixture was taken into chloroform, and washed with water (2×20 mL) and
brine (20 mL). The organic phase was dried with magnesium sulfate, filtered and
concentrated under reduced pressure. The crude product was recrystallized from 1:2
acetone-water. Yield 4.54 g (91 %) of colorless crystal product 15.
Mp 246-248 oC (lit: 246-248 oC).
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1H NMR (CDCl3, 300 MHz): δ 2.70 (s. CH2).
13C NMR (DMSO-d6, 100 MHz): δ 57.34 (CH2), 52.93 (C-Br).
MS (EI): no molecular ion, 375/373/371/369 (28/98/100/30), 329/327/325 (13/18/8),
293/291/289 (6/12/6), 213/211/209 (10/16/6), 130 (15), 115 (10).
15.10. Attempted synthesis of 1,3,5,7-Tetraiodoadamantane 16
AlBr3 (58.0 mg, 0.440 mmol) in iodomethane (3.00 mL, 48.0 mmol) was stirred at
room temp for 30 min. Tetrabromoadamantane 15 (100 mg, 0.220 mmol) was added
and the reaction mixture was stirred for 20 h. The mixture was treated with
concentrated NaHSO3 aq. (50 mL) and 6N HCl (25 mL). The resulting mixture was
extraced with chloroform, washed with water and brine, and dried with magnesium
sulfate. From 1H NMR spectra of reaction mixture and organic phase after extraction,
only starting material 15 was observed.
15.11. Attempted synthesis of 1, 3, 5, 7-tetrathymineadamantane 17
K2CO3 (30.5 mg, 0.220 mmol) were added to a solution of thymine 9 (126 mg, 1.00
mmol) in DMF and stirred for 1 h. 1,3,5,7-tetrabromoadamantane 15 (100 mg, 0.220
mmol) was added into the mixture and stirred at 60 °C for 48 h or at 160 °C for 24 h.
The reaction mixture was filtered and some insoluble solid was remained on filter
paper, while washing with water, the solid dissolved. From 1H NMR spectrum of
filtrate, no target compound 17 was observed.
15.12. Attempted synthesis of 1, 3, 5, 7-tetrauraciladamantane 19.
K2CO3 (30.5 mg, 0.220 mmol) were added to a solution of uracil 18 (112 mg, 1.00
mmol) in DMF and stirred for 1 h. 1,3,5,7-tetrabromoadamantane 15 (100 mg, 0.220
mmol) was added into the mixture and stirred at 60 °C for 24 h, or at 160oC for 24 h.
After getting rid of solvent, the residue was applied into column with eluent system of
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8 % MeOH in dichloromethane. 19 mg unknown solid was obtained. From 1H NMR
spectrum of this solid product, there was no signal indicating the target compound 19.
15.13. Tetrakis(4-(bromomethyl)phenyl)methane 21
Tetraphenylmethane 20 (1.28 g, 4.00 mmol) and titanium tetrabromide (4.40 g, 12.0
mmol) were stirred in dry dichloromethane (20 mL). To the reaction mixture, cooled
in an ice-bath, add bromomethoxymethane (2.70 g, 20.0 mmol) dropwise. The
mixture was stirred at room temperature under N2 atmosphere for 28 h, and then water
(20 mL) was added dropwise. The resulting mixture was extracted with
dichloromethane (3×50 mL). The combined organic phase was washed with water
(2×20 mL) and brine (20 mL), dried over MgSO4 and concentrated under reduced
pressure, the product 21 was obtained by recrystallization from CH2Cl2 as a colorless
solid. Yield: 1.61 g (58 %).
M.p. 284-286 oC (lit. 126 285-286 oC).
1H NMR (CDCl3, 300 MHz): δ 7.29-7.18 (m, 16 H, Ph), 4.47 (s, 8 H, CH2).
13C NMR (CDCl3, 75 MHz): δ 146.46, 135.81, 131.37, 128.61, 64.50, 33.24.
MS (EI): 692 (2, M+), 613/611 (24/24), 600/598 (13/13), 519 (100), 431/429/427
(13/29/18), 361 (11).
15.14. Tetrakis(4-thyminylmethylphenyl)methane 22
Step 1:
The intermediate product O,O’ bis(trimethylsilyl)thymine 10 was synthesized in the
same way as described in 15.6 Step 1.
Step 2:
The silylated thymine 10 from first step was dissolved in DMF (15 ml). Tetra bromide
compound 21 (415 mg, 0.600 mmol) was added. The reaction mixture was stirred
under N2 (g) and heated to 160 oC for 24 hours. The resulting mixture was cooled to
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room temperature, and concentrated under reduced pressure to give solid mixture as
crude product. The crude product was purified by flash chromatography for twice,
using the same eluent system of 5 % MeOH saterated with NH3 in DCM. The pure
product was obtained as colorless powder with the yield of 255 mg (49 %).
M.p. >380 oC.
1H NMR (DMSO-d6, 600 MHz): δ 11.28 (s, 4H, Th H2), 7.61 (s, 4H, Th H6), 7.16 (m,
16 H, Ph), 4.78 (s, 8 H, CH2), 1.73 (d, 12H, Th CH3).
13C NMR (DMSO-d6, 150 MHz): δ 164.26, 150.98, 145.65, 141.44, 134.57, 130.40,
126.64, 109.00, 63.73, 49.60, 11.95.
MS (ESI): 895.3 (100, M+Na).
15.15. Tetrakis(4-adeninylmethylphenyl)methane 23
Adenine (616 mg, 4.56 mmol) and potassium carbonate (1.05 g, 7.60 mmol) were
mixed in DMF (20 ml). After 1 h, tetra bromide compound 21 (529 mg, 0.760 mmol)
was added. The mixture was stirred under N2 at ambient temperature for 38 hours.
After filtration of resulting mixture with Buchner funnel, the filtrate was concentrated
under reduced pressure and dried under high vacuum to remove DMF. The crude
product was applied to column for three times, using the eluent system of 5 % MeOH
saterated with NH3 in DCM. The best purity of product 23 reached ca. 90 %.
1H NMR (DMSO-d6, 300 MHz): δ 8.20 (s, 4 H, Ad H2), 8.11 (s, 4 H, Ad H8), 7.22 (s,
8 H, Ad NH2), 7.06- 7.15 (m, 16 H, Ph), 5.27 (s, 8 H, CH2).
13C NMR (DMSO-d6, 75 MHz): δ 155.96, 152.61, 149.43, 145.71, 140.81, 134.64,
130.38, 126.88, 118.58, 63.71, 45.51.
MS (ESI): 931.4 (86, M+Na). 158.1 (100)
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16. Crystal growing
16.1. General setup
16.1.1. Vapor diffusion:
A small straight-wall vial containing the starting materials dissolved in a specific
solvent was covered with parafilm which was stabbed a tiny hole on it to allow for
vapour diffusion. This vial was placed in a bigger vial with lid and precipitating
reagent (ca. 2 mL) inside. The big vial was subsequently capped and stored at ambient
temperature without disturbing (Picture 3).
Picture 3: The general setup of crystal growth by the method of
vapor diffusion.
16.1.2. Slow evaporation
A small straight wall and round bottom vial containing the starting materials dissolved
in a specific solvent was covered with parafilm which was stabbed a tiny hole on it to
allow the evaporation of solvent. This setup was placed in a hood at ambient
temperature without disturbing.
16.2. Crystal growth of AdC2Ad (2)
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Using the vapor diffusion method, in the small vial 2.9 mg of 9,9’-dimethylene-
bis(adenine) 2 (AdC2Ad) was dissolved in HFP (0.3 mL). MeOH, MeCN and DCM
were chosen separately as precipitating reagent in the big vial. This whole setup was
left at ambient temperature for approximately 1 week, and only amorphous powder
was precipitated.
16.3. Crystal growth of ThC2Th (11)
For vapor diffusion, in the small vial 2.7 mg of 1,1’- bimethylene-bis(thymine) 11
(ThC2Th) was dissolved in HFP (0.3 mL). MeOH, MeCN and DCM were tried
separately as precipitating reagent in the big vial. This whole setup was stored at
ambient temperature for approximately 5 days, and only amorphous powder was
observed.
16.4. Crystal growth of ThC2Th (11)-AdC2Ad (2) complex
Using vapor diffusion method, in the small vial a mixture of 2.7 mg ThC2Th 11 and
2.9 mg AdC2Ad 2 (ratio 1:1) was dissolved in HFP (0.3 mL). MeOH, MeCN EtOAc
and DCM were tried separately as precipitating reagent in the big vial. All the setups
were stored at ambient temperature for approximately 1 week, but for all of them only
amorphous powder was observed.
16.5. Crystal growth of Th4 (22)
With vapor diffusion method, in the small vial 4.4 mg ThC4 22 was dissolved in
mixed solvent of MeOH and DCM (0.3 mL). MeCN was applied as precipitating
reagent in the big vial. The setup was stored at ambient temperature for approximately
1 week, but only amorphous powder was observed.
For slow evaporation, HFP, DMSO and mixed solvent of MeOH-DCM were chosen
as the specific solvent.
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16.6. Crystal growth of Th4 (22)-AdC2Ad(2) complex
According to slow evaporation, 2.9 mg AdC2Ad 2 and 4.4 mg Th4 22 (ratio 2:1) were
dissolved in HFP or DMSO (0.3 mL) in a suitable vial. The setup was left in the hood
for 2 days or 10 days.
Using vapor diffusion method and setup, in the small vial 2.9 mg AdC2Ad and 4.4 mg
Th4 (ratio 2:1) were dissolved in HFP (0.3 mL). MeOH, MeCN EtOAc, IPA, H2O
and DCM were used separately as precipitating reagent in the big vial. Each setup was
left at ambient temperature for 1-2 weeks, and various phenomena were observed as
in Table 5.
16.7. Crystal growth of Th4 (22)-AdC3Ad (3) complex
Similar to that for Th4-AdC2Ad complex, vapor diffusion method was used in a scale
of 3.1 mg AdC3Ad 3 and 4.4 mg Th4 22 (ratio 2:1). MeOH, MeCN EtOAc, IPA, H2O
and DCM were used separately as precipitating reagent. Each setup was left at
ambient temperature for 1-2 weeks, and the phenomena were observed as in Table 5.
17. X-ray diffractions
17.1. Crystal handling
For the unstable and sensitive crystals, flash frozen technique in liquid nitrogen was
used to minimize the solvent evaporation time. As soon as the suitable crystal was
picked up under a microscope, it was put into liquid nitrogen.
17.2. Single crystal XRD data collection
The crystal data was collected on a single-crystal X-ray diffractometer using Mo as
radiation source and liquid nitrogen to maintain the constant temperature of sample
environment. Firstly, to examine the crystal quality, a quick scan of twenty-four
frames of diffractions was collected at 100K, so that the unit cell of crystal lattice can
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be determined. Then the program calculated and set up the data collection strategy
according to which the whole process took several hours.
95
Appendix
1. NMR spectra....................................................................................................... 96
2. PXRD patterns.................................................................................................. 128
3. Single crystal data.............................................................................................143
3.1. Th4 crystal from HFP-MeOH.................................................................. 143
3.2. AdC2Ad crystal from HFP-DCM............................................................ 151
3.3. Th4 crystal from HFP- IPA...................................................................... 160
96
1. NMR spectra
Spectrum 1: 1H NMR spectrum of 9,9’-dimethylene-bis(adenine) (2)
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Spectrum 2: 13C NMR spectrum of 9,9’-dimethylene-bis(adenine) (2)
Spectrum 3: COSY spectrum of 9,9’-dimethylene-bis(adenine) (2)
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Spectrum 4: HSQC spectrum of 9,9’-dimethylene-bis(adenine) (2)
Spectrum 5: HMBC spectrum of 9,9’-dimethylene-bis(adenine) (2)
99
Spectrum 6: 1H NMR spectrum of 9,9’-trimethylene-bis(adenine) (3)
Spectrum 7: 13C NMR spectrum of 9,9’-trimethylene-bis(adenine) (3)
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Spectrum 8: HSQC spectrum of 9,9’-trimethylene-bis(adenine) (3)
Spectrum 9: HMBC spectrum of 9,9’-trimethylene-bis(adenine) (3)
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Spectrum 10: COSY spectrum of 9,9’-trimethylene-bis(adenine) (3)
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Spectrum 11: 1H NMR spectrum of pentaerythrityl bromide (6)
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Spectrum 11: 1H NMR spectrum of pentaerythrityl iodide 7
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Spectrum 12: 1H NMR spectrum of 8a
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Spectrum 13: 1H NMR spectrum of 1,1’- trimethylene-bis(thymine) (11)
Spectrum 14: 13C NMR spectrum of 1,1’- trimethylene-bis(thymine) (11)
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Spectrum 15: HMBC spectrum of 1,1’- trimethylene-bis(thymine) (11)
Spectrum 16:HSQC spectrum of 1,1’- trimethylene-bis(thymine) (11)
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Spectrum 17: COSY spectrum of 1,1’- trimethylene-bis(thymine) (11)
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Spectrum 18: 1H NMR spectrum of 1,1’- bimethylene-bis(thymine) (12)
Spectrum 19: 13C NMR spectrum of 1,1’- bimethylene-bis(thymine) (12)
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Spectrum 20: HMQC spectrum of 1,1’- bimethylene-bis(thymine) (12)
Spectrum 21: HMBC spectrum of 1,1’- bimethylene-bis(thymine) (12)
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Spectrum 22: COSYspectrum of 1,1’- bimethylene-bis(thymine) (12)
111
Spectrum 23: 1H NMR spectrum of 1,3,5,7-tetrabromoadamantane (15)
Spectrum 24: 13C NMR spectrum of 1,3,5,7-tetrabromoadamantane (15)
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Spectrum 25: 1H NMR spectrum of tetrakis(4-(bromomethyl)phenyl)methane
(21)
Spectrum 26: 13C NMR spectrum of tetrakis(4-(bromomethyl)phenyl)methane
(21)
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Spectrum 27: 1H NMR spectrum of tetrakis(4-thyminylmethylphenyl)methane
(22)
Spectrum 28: 13C NMR spectrum of tetrakis(4-thyminylmethylphenyl)methane
(22)
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Spectrum 29: HMBC spectrum of tetrakis(4-thyminylmethylphenyl)methane (22)
Spectrum 30: HSQC spectrum of tetrakis(4-thyminylmethylphenyl)methane (22)
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Spectrum 31: COSY spectrum of tetrakis(4-thyminylmethylphenyl)methane (22)
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Spectrum 32: 1H NMR spectrum of tetrakis(4-adeninylmethylphenyl)methane
(23)
Spectrum 33: 13C NMR spectrum of tetrakis(4-adeninylmethylphenyl)methane
(23)
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Spectrum 34: HSQC spectrum of tetrakis(4-adeninylmethylphenyl)methane (23)
Spectrum 35: HMBC spectrum of tetrakis(4-adeninylmethylphenyl)methane (23)
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Spectrum 36: COSY spectrum of tetrakis(4-adeninylmethylphenyl)methane (23)
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2. PXRD patterns
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Figure A1: PXRD pattern of 1,1’- dimethylene-bis(thymine) (12) ThC2Th
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Figure A2: PXRD pattern of 1,1’- dimethylene-bis(adenine) (2) AdC2Ad
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Figure A3: PXRD pattern of mixture of AdC2Ad-ThC2Th from vapor diffusion
of HFP-MeOH
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Figure A4: PXRD pattern of mixture of AdC2Ad-ThC2Th grinded in H2O
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Figure A5: PXRD pattern of mixture of AdC2Ad-ThC2Th grinded in DMSO
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Figure A6: PXRD pattern of mixture of AdC2Ad-ThC2Th grinded in toluene
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Figure A7: PXRD pattern of mixture of AdC2Ad-ThC2Th grinded in acetic acid
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Figure A8: PXRD pattern of mixture of AdC2Ad-ThC2Th from DMSO in
ultrasonic bath for 5 h
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Figure A9: PXRD pattern of mixture of AdC2Ad-ThC2Th from H2O in
ultrasonic bath for 5 h
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Figure A10: PXRD pattern of mixture of AdC2Ad-ThC2Th from toluene in
ultrasonic bath for 5 h
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Figure A11: PXRD pattern of mixture of AdC2Ad-ThC2Th heated to 210 oC for
5 min
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Figure A12: PXRD pattern of mixture of AdC2Ad-ThC2Th heated to 250 oC for
5 min
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Figure A13: PXRD pattern of mixture of AdC2Ad-ThC2Th heated to 300 oC for
5 min
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Figure A14: PXRD pattern of mixture of AdC2Ad-ThC2Th heated to 350 oC for
5 min
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3. Single crystal data
3.1. Th4 crystal from HFP-MeOH
Cif for Th4 from HFP-MeOH (lists of coordinates and molecular geometry
parameters have been left out).
data_Th4 from HFP-MeOH
_audit_creation_method SHELXL-2013
_chemical_name_systematic C49H44N8O8
_chemical_name_common ?
_chemical_melting_point ?
_chemical_formula_moiety ?
_chemical_formula_sum 'C24.75 H23 N4 O4.25'
_chemical_formula_weight 444.47
loop_
_atom_type_symbol
_atom_type_description
_atom_type_scat_dispersion_real
_atom_type_scat_dispersion_imag
_atom_type_scat_source
'C' 'C' 0.0033 0.0016
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'
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'H' 'H' 0.0000 0.0000
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'
'N' 'N' 0.0061 0.0033
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'
'O' 'O' 0.0106 0.0060
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'
_space_group_crystal_system triclinic
_space_group_IT_number 2
_space_group_name_H-M_alt 'P -1'
_space_group_name_Hall '-P 1'
_shelx_space_group_comment
;
The symmetry employed for this shelxl refinement is
uniquely defined
by the following loop, which should always be used as a
source of
symmetry information in preference to the above space-group
names.
They are only intended as comments.
loop_
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_space_group_symop_operation_xyz
'x, y, z'
'-x, -y, -z'
_cell_length_a 14.4613(17)
_cell_length_b 20.326(2)
_cell_length_c 23.303(3)
_cell_angle_alpha 65.194(3)
_cell_angle_beta 85.341(3)
_cell_angle_gamma 73.765(3)
_cell_volume 5964.7(12)
_cell_formula_units_Z 8
_cell_measurement_temperature 100(2)
_cell_measurement_reflns_used ?
_cell_measurement_theta_min ?
_cell_measurement_theta_max ?
_exptl_crystal_description ?
_exptl_crystal_colour ?
_exptl_crystal_density_meas ?
_exptl_crystal_density_method ?
_exptl_crystal_density_diffrn 0.990
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_exptl_crystal_F_000 1868
_exptl_transmission_factor_min ?
_exptl_transmission_factor_max ?
_exptl_crystal_size_max ?
_exptl_crystal_size_mid ?
_exptl_crystal_size_min ?
_exptl_absorpt_coefficient_mu 0.069
_shelx_estimated_absorpt_T_min ?
_shelx_estimated_absorpt_T_max ?
_exptl_absorpt_correction_type ?
_exptl_absorpt_correction_T_min ?
_exptl_absorpt_correction_T_max ?
_exptl_absorpt_process_details ?
_exptl_special_details
_diffrn_ambient_temperature 100(2)
_diffrn_radiation_wavelength 0.71073
_diffrn_radiation_type MoK\a
_diffrn_source ?
_diffrn_measurement_device_type ?
_diffrn_measurement_method ?
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_diffrn_detector_area_resol_mean ?
_diffrn_reflns_number 88019
_diffrn_reflns_av_unetI/netI 0.0699
_diffrn_reflns_av_R_equivalents 0.0834
_diffrn_reflns_limit_h_min -15
_diffrn_reflns_limit_h_max 15
_diffrn_reflns_limit_k_min -22
_diffrn_reflns_limit_k_max 22
_diffrn_reflns_limit_l_min -25
_diffrn_reflns_limit_l_max 25
_diffrn_reflns_theta_min 2.087
_diffrn_reflns_theta_max 22.722
_diffrn_reflns_theta_full 25.242
_diffrn_measured_fraction_theta_max 0.998
_diffrn_measured_fraction_theta_full 0.742
_diffrn_reflns_Laue_measured_fraction_max 0.998
_diffrn_reflns_Laue_measured_fraction_full 0.742
_diffrn_reflns_point_group_measured_fraction_max 0.998
_diffrn_reflns_point_group_measured_fraction_full 0.742
_reflns_number_total 16010
_reflns_number_gt 10446
_reflns_threshold_expression 'I > 2\s(I)'
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_reflns_Friedel_coverage 0.000
_reflns_Friedel_fraction_max .
_reflns_Friedel_fraction_full .
_reflns_special_details
;
Reflections were merged by SHELXL according to the crystal
class for the calculation of statistics and refinement.
Structure factors included contributions from the .fab
file.
_reflns_Friedel_fraction is defined as the number of
unique
Friedel pairs measured divided by the number that would be
possible theoretically, ignoring centric projections and
systematic absences.
_computing_data_collection ?
_computing_cell_refinement ?
_computing_data_reduction ?
_computing_structure_solution ?
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_computing_structure_refinement 'SHELXL-2013 (Sheldrick,
2013)'
_computing_molecular_graphics ?
_computing_publication_material ?
_refine_special_details
_refine_ls_structure_factor_coef Fsqd
_refine_ls_matrix_type full
_refine_ls_weighting_scheme calc
_refine_ls_weighting_details
;
w=1/[\s^2^(Fo^2^)+(0.0907P)^2^+6.8839P]
where P=(Fo^2^+2Fc^2^)/3
;
_atom_sites_solution_primary ?
_atom_sites_solution_secondary ?
_atom_sites_solution_hydrogens mixed
_refine_ls_hydrogen_treatment mixed
_refine_ls_extinction_method none
_refine_ls_extinction_coef .
_refine_ls_number_reflns 16010
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_refine_ls_number_parameters 1201
_refine_ls_number_restraints 794
_refine_ls_R_factor_all 0.1112
_refine_ls_R_factor_gt 0.0727
_refine_ls_wR_factor_ref 0.2045
_refine_ls_wR_factor_gt 0.1814
_refine_ls_goodness_of_fit_ref 1.032
_refine_ls_restrained_S_all 1.009
_refine_ls_shift/su_max 0.000
_refine_ls_shift/su_mean 0.000
Hydrogen-bond geometry (Å, o)
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3.2. AdC2Ad crystal from HFP-DCM
Cif for AdC2Ad from HFP-DCM (lists of molecular geometry parameters have been
left out).
data_ AdC2Ad from HFP-DCM
_audit_creation_method 'SHELXL-2014/7'
_shelx_SHELXL_version_number '2014/7'
_chemical_name_systematic C12H12N10
_chemical_name_common ?
_chemical_melting_point ?
_chemical_formula_moiety ?
_chemical_formula_sum
'C24 H20 F24 N10 O4'
_chemical_formula_weight 968.50
loop_
_atom_type_symbol
_atom_type_description
_atom_type_scat_dispersion_real
_atom_type_scat_dispersion_imag
_atom_type_scat_source
'C' 'C' 0.0033 0.0016
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'
'H' 'H' 0.0000 0.0000
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'
'N' 'N' 0.0061 0.0033
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'
'O' 'O' 0.0106 0.0060
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'
'F' 'F' 0.0171 0.0103
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'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'
_space_group_crystal_system triclinic
_space_group_IT_number 2
_space_group_name_H-M_alt 'P -1'
_space_group_name_Hall '-P 1'
_shelx_space_group_comment
;
The symmetry employed for this shelxl refinement is
uniquely defined
by the following loop, which should always be used as a
source of
symmetry information in preference to the above space-group
names.
They are only intended as comments.
loop_
_space_group_symop_operation_xyz
'x, y, z'
'-x, -y, -z'
_cell_length_a 7.1752(7)
_cell_length_b 10.3078(10)
_cell_length_c 12.3995(12)
_cell_angle_alpha 86.613(2)
_cell_angle_beta 87.488(2)
_cell_angle_gamma 71.906(2)
_cell_volume 869.89(15)
_cell_formula_units_Z 1
_cell_measurement_temperature 100(2)
_cell_measurement_reflns_used ?
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_cell_measurement_theta_min ?
_cell_measurement_theta_max ?
_exptl_crystal_description ?
_exptl_crystal_colour ?
_exptl_crystal_density_meas ?
_exptl_crystal_density_method ?
_exptl_crystal_density_diffrn 1.849
_exptl_crystal_F_000 482
_exptl_transmission_factor_min ?
_exptl_transmission_factor_max ?
_exptl_crystal_size_max ?
_exptl_crystal_size_mid ?
_exptl_crystal_size_min ?
_exptl_absorpt_coefficient_mu 0.213
_shelx_estimated_absorpt_T_min ?
_shelx_estimated_absorpt_T_max ?
_exptl_absorpt_correction_type ?
_exptl_absorpt_correction_T_min ?
_exptl_absorpt_correction_T_max ?
_exptl_absorpt_process_details ?
_exptl_absorpt_special_details ?
_diffrn_ambient_temperature 100(2)
_diffrn_radiation_wavelength 0.71073
_diffrn_radiation_type MoK\a
_diffrn_source ?
_diffrn_measurement_device_type ?
_diffrn_measurement_method ?
_diffrn_detector_area_resol_mean ?
_diffrn_reflns_number 21096
_diffrn_reflns_av_unetI/netI 0.0242
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_diffrn_reflns_av_R_equivalents 0.0281
_diffrn_reflns_limit_h_min -9
_diffrn_reflns_limit_h_max 9
_diffrn_reflns_limit_k_min -14
_diffrn_reflns_limit_k_max 14
_diffrn_reflns_limit_l_min -17
_diffrn_reflns_limit_l_max 17
_diffrn_reflns_theta_min 2.081
_diffrn_reflns_theta_max 29.652
_diffrn_reflns_theta_full 25.242
_diffrn_measured_fraction_theta_max 0.994
_diffrn_measured_fraction_theta_full 0.997
_diffrn_reflns_Laue_measured_fraction_max 0.994
_diffrn_reflns_Laue_measured_fraction_full 0.997
_diffrn_reflns_point_group_measured_fraction_max 0.994
_diffrn_reflns_point_group_measured_fraction_full 0.997
_reflns_number_total 4878
_reflns_number_gt 3936
_reflns_threshold_expression 'I > 2\s(I)'
_reflns_Friedel_coverage 0.000
_reflns_Friedel_fraction_max .
_reflns_Friedel_fraction_full .
_reflns_special_details
;
Reflections were merged by SHELXL according to the crystal
class for the calculation of statistics and refinement.
_reflns_Friedel_fraction is defined as the number of
unique
Friedel pairs measured divided by the number that would be
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possible theoretically, ignoring centric projections and
systematic absences.
_computing_data_collection ?
_computing_cell_refinement ?
_computing_data_reduction ?
_computing_structure_solution ?
_computing_structure_refinement 'SHELXL-2014/7 (Sheldrick,
2014)'
_computing_molecular_graphics ?
_computing_publication_material ?
_refine_special_details ?
_refine_ls_structure_factor_coef Fsqd
_refine_ls_matrix_type full
_refine_ls_weighting_scheme calc
_refine_ls_weighting_details
'w=1/[\s^2^(Fo^2^)+(0.0347P)^2^+0.4485P] where
P=(Fo^2^+2Fc^2^)/3'
_atom_sites_solution_primary ?
_atom_sites_solution_secondary ?
_atom_sites_solution_hydrogens difmap
_refine_ls_hydrogen_treatment refxyz
_refine_ls_extinction_method none
_refine_ls_extinction_coef .
_refine_ls_number_reflns 4878
_refine_ls_number_parameters 319
_refine_ls_number_restraints 0
_refine_ls_R_factor_all 0.0506
_refine_ls_R_factor_gt 0.0365
_refine_ls_wR_factor_ref 0.0884
_refine_ls_wR_factor_gt 0.0818
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_refine_ls_goodness_of_fit_ref 1.025
_refine_ls_restrained_S_all 1.025
_refine_ls_shift/su_max 0.000
_refine_ls_shift/su_mean 0.000
Fractional atomic coordinates and isotropic or equivalent isotropic displacement
parameters (Å2)
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Atomic displacement parameters (Å2)
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Hydrogen-bond geometry (Å, o)
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3.3. Th4 crystal from HFP- IPA
Cif for Th4 from HFP-IPA (lists of coordinates and molecular geometry parameters
have been left out).
data_ Th4 from HFP-IPA
_audit_creation_method SHELXL-2013
_chemical_name_systematic C49H44N8O8
_chemical_name_common ?
_chemical_melting_point ?
_chemical_formula_moiety ?
_chemical_formula_sum
'C49 H44 N8 O8'
_chemical_formula_weight 872.92
loop_
_atom_type_symbol
_atom_type_description
_atom_type_scat_dispersion_real
_atom_type_scat_dispersion_imag
_atom_type_scat_source
'C' 'C' 0.0033 0.0016
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'
'H' 'H' 0.0000 0.0000
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'
'N' 'N' 0.0061 0.0033
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'
'O' 'O' 0.0106 0.0060
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'
_space_group_crystal_system monoclinic
_space_group_IT_number 14
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_space_group_name_H-M_alt 'P 21/c'
_space_group_name_Hall '-P 2ybc'
_shelx_space_group_comment
;
The symmetry employed for this shelxl refinement is
uniquely defined
by the following loop, which should always be used as a
source of
symmetry information in preference to the above space-group
names.
They are only intended as comments.
loop_
_space_group_symop_operation_xyz
'x, y, z'
'-x, y+1/2, -z+1/2'
'-x, -y, -z'
'x, -y-1/2, z-1/2'
_cell_length_a 14.9614(17)
_cell_length_b 15.2536(16)
_cell_length_c 30.990(4)
_cell_angle_alpha 90
_cell_angle_beta 96.288(3)
_cell_angle_gamma 90
_cell_volume 7029.9(14)
_cell_formula_units_Z 4
_cell_measurement_temperature 100(2)
_cell_measurement_reflns_used ?
_cell_measurement_theta_min ?
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_cell_measurement_theta_max ?
_exptl_crystal_description ?
_exptl_crystal_colour ?
_exptl_crystal_density_meas ?
_exptl_crystal_density_method ?
_exptl_crystal_density_diffrn 0.825
_exptl_crystal_F_000 1832
_exptl_transmission_factor_min ?
_exptl_transmission_factor_max ?
_exptl_crystal_size_max ?
_exptl_crystal_size_mid ?
_exptl_crystal_size_min ?
_exptl_absorpt_coefficient_mu 0.057
_shelx_estimated_absorpt_T_min ?
_shelx_estimated_absorpt_T_max ?
_exptl_absorpt_correction_type ?
_exptl_absorpt_correction_T_min ?
_exptl_absorpt_correction_T_max ?
_exptl_absorpt_process_details ?
_exptl_special_details
_diffrn_ambient_temperature 100(2)
_diffrn_radiation_wavelength 0.71073
_diffrn_radiation_type MoK\a
_diffrn_source ?
_diffrn_measurement_device_type ?
_diffrn_measurement_method ?
_diffrn_detector_area_resol_mean ?
_diffrn_reflns_number 54204
152
_diffrn_reflns_av_unetI/netI 0.0689
_diffrn_reflns_av_R_equivalents 0.0697
_diffrn_reflns_limit_h_min -16
_diffrn_reflns_limit_h_max 15
_diffrn_reflns_limit_k_min -16
_diffrn_reflns_limit_k_max 16
_diffrn_reflns_limit_l_min -34
_diffrn_reflns_limit_l_max 34
_diffrn_reflns_theta_min 2.072
_diffrn_reflns_theta_max 23.278
_diffrn_reflns_theta_full 25.242
_diffrn_measured_fraction_theta_max 0.991
_diffrn_measured_fraction_theta_full 0.790
_diffrn_reflns_Laue_measured_fraction_max 0.991
_diffrn_reflns_Laue_measured_fraction_full 0.790
_diffrn_reflns_point_group_measured_fraction_max 0.991
_diffrn_reflns_point_group_measured_fraction_full 0.790
_reflns_number_total 10044
_reflns_number_gt 6141
_reflns_threshold_expression 'I > 2\s(I)'
_reflns_Friedel_coverage 0.000
_reflns_Friedel_fraction_max .
_reflns_Friedel_fraction_full .
_reflns_special_details
;
Reflections were merged by SHELXL according to the crystal
class for the calculation of statistics and refinement.
Structure factors included contributions from the .fab
file.
153
_reflns_Friedel_fraction is defined as the number of
unique
Friedel pairs measured divided by the number that would be
possible theoretically, ignoring centric projections and
systematic absences.
_computing_data_collection ?
_computing_cell_refinement ?
_computing_data_reduction ?
_computing_structure_solution ?
_computing_structure_refinement 'SHELXL-2013 (Sheldrick,
2013)'
_computing_molecular_graphics ?
_computing_publication_material ?
_refine_special_details
_refine_ls_structure_factor_coef Fsqd
_refine_ls_matrix_type full
_refine_ls_weighting_scheme calc
_refine_ls_weighting_details
;
w=1/[\s^2^(Fo^2^)+(0.0868P)^2^+7.8921P]
where P=(Fo^2^+2Fc^2^)/3
;
_atom_sites_solution_primary ?
_atom_sites_solution_secondary ?
_atom_sites_solution_hydrogens geom
_refine_ls_hydrogen_treatment constr
_refine_ls_extinction_method none
_refine_ls_extinction_coef .
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_refine_ls_number_reflns 10044
_refine_ls_number_parameters 590
_refine_ls_number_restraints 0
_refine_ls_R_factor_all 0.1274
_refine_ls_R_factor_gt 0.0796
_refine_ls_wR_factor_ref 0.2275
_refine_ls_wR_factor_gt 0.1997
_refine_ls_goodness_of_fit_ref 1.080
_refine_ls_restrained_S_all 1.080
_refine_ls_shift/su_max 0.000
_refine_ls_shift/su_mean 0.000
Hydrogen-bond geometry (Å, o)
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